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Coagulase-negative staphylococci (CoNS) are among the most commonly recovered 
bacteria in clinical specimens. They are usually colonisers (commensals) of the skin 
and nasal passages and considered contaminants of microbial cultures. However, they 
have been recognised as emerging pathogens, frequently causing opportunistic 
infections. The frequent use of indwelling medical devices and long-term 
hospitalisation present an increased risk of exposure to CoNS, resulting in infections 
usually caused by multidrug-resistant pathogens.  
Few studies focus on CoNS, including characterisation of their mechanisms of 
resistance, virulence, and persistence. Therefore, this study describes the molecular and 
genomic profiles of clinical CoNS from public sector hospitals in the uMgungundlovu 
District in KwaZulu-Natal, South Africa. 
Eighty-nine clinical CoNS isolates collected from three hospitals within the 
uMgungundlovu District between October 2019 and February 2020, constituted the 
sample. Isolates were speciated using the Vitek 2 system. Antibiotic susceptibility 
testing was done against a panel of 20 antibiotics according to Clinical and Laboratory 
Standards Institute (CLSI) guidelines using the Kirby-Bauer disk-diffusion method and 
minimum inhibitory concentration (MIC) was determined using the broth microdilution 
method for penicillin G, cefoxitin, ceftaroline, ciprofloxacin, moxifloxacin, 
azithromycin, erythromycin, gentamicin, amikacin, chloramphenicol, tetracycline, 
doxycycline, teicoplanin, tigecycline, linezolid, clindamycin, rifampicin, 
sulphamethoxazole/trimethoprim, nitrofurantoin and vancomycin. PCR was used to 
detect the presence of the mecA gene to confirm phenotypic methicillin resistance.  
Based on their resistance profiles, a sub-sample of isolates were subjected to whole-




clonality and phylogenomic relationships using bioinformatic tools. The SPAdes 
software was used for the assembly of the raw reads. ResFinder 4.1 and CARD were 
used to identify antibiotic resistance genes in the isolates, while the virulence factor 
database (VFDB), Center for Genomic Epidemiology‘s MLST 2.0 server and 
MobileElementFinder v1.0.3 were used to identify virulence genes, sequence types and 
mobile genetic elements, respectively. Mutations in fluoroquinolone and rifampicin 
resistance genes were identified by manual curation using BLASTn alignment which 
was also used to determine the genetic environment of the resistance genes. 
S. epidermidis was the most abundant CoNS species isolated. Phenotypic methicillin-
resistance was detected in 76.4% (n=68) of isolates, 92.6% (n=63) of which were 
genotypically confirmed by PCR. Multidrug resistance (MDR) was observed in 76.4% 
(n=68) of isolates, with 51 antibiograms observed. The resistance genes mecA, blaZ, 
erm(A), erm(B), erm(C), msr(A), aac(6')-aph(2'') and fosB, among others, were detected 
and corroborated the observed phenotypes. Molecular mechanisms of resistance to 
tigecycline, teicoplanin, linezolid and nitrofurantoin were not detected even though 
some isolates were resistant to them. There was no association between ARG type and 
hospital/department. The ica operon known to facilitate biofilm formation was detected 
in 7/16 isolates sequenced. Known and putatively novel mutations in the gyrA, parC, 
parE and rpoB genes were also detected for fluoroquinolone- and rifampicin-resistant 
isolates. Prediction of isolates’ pathogenicity towards human hosts yielded a high 
average probability score (Pscore ≈ 0.936), which, together with the several virulence 
genes detected (including atl, ebh, clfA, ebp, icaA, icaB,icaC), support their pathogenic 
potential to humans.  
Seven MLST types were found, while the community-acquired SCCmec type IV was 




by isolates included plasmid replicon Rep10 and insertion sequence IS256. Defense 
systems such as arginine catabolic mobile element (type I and III), CRISPR system 
(16), and the restriction-modification system (type II) were detected. Genetic analysis 
showed that resistance genes were frequently bracketed by MGEs such as transposons 
(such as Tn554) and insertion sequences (such as IS257 and IS1182) that facilitated 
their mobility. Phylogenetic studies showed that the distribution of genes did not 
coincide with the phylogenetic clades. Despite the relatedness of isolates (clades A and 
B), there is still considerable variation within individual strains that can facilitate 
adaptation to local environments.  The isolates exhibited several permutations and 
combinations of ARGs, virulence genes and MGEs, pointing to a complex milieu of 
mobilized antibiotic resistance and pathogenic characteristics in clonal and multiclonal 





CHAPTER 1 - INTRODUCTION AND LITERATURE REVIEW 
1.0 Introduction 
Antibiotic resistance has become a subject of global interest, especially as the use of antibiotics 
continues to rise in both clinical and veterinary practice. Bacteria adapt to the effects of 
antibiotics in several ways to enable them to survive in therapeutic concentrations of antibiotics 
(Osei Sekyere and Asante, 2018).  Thus, infections caused by pathogenic bacteria have become 
increasingly difficult to treat due to the various antibiotic resistance mechanisms deployed by 
bacteria to evade the effects of antibiotics (Holmes et al., 2015, Osei Sekyere and Asante, 
2018).  
Also implicated in antibiotic resistance are the so-called persister cells, which can survive 
under low metabolic states in the presence of antibiotics. Persister cells are so named because 
they can persist under the stress of antibiotics due to their metabolic inactivity (Lee et al., 2016, 
Osei Sekyere and Asante, 2018). The nondividing nature of persister cells is central to their 
ability to withstand the lethal effects of antibiotics because binding to drug target sites will not 
be able to alter cells’ activities. Persister cells are thought to be able to transfer resistance traits 
to non-persisters, rendering them resistant (Lewis, 2010, Wood et al., 2013).  
Coagulase-negative staphylococci (CoNS), major components of the normal flora of the skin 
and mucous membranes, are amongst the most frequently recovered bacterial species in 
microbiology laboratories, where they are mostly regarded as contaminants in microbiological 
cultures (Asante et al., 2020). The pathogenic potential of CoNS has been underestimated for 
a long period. However, they have been recognised as opportunistic pathogens, often causing 
multidrug-resistant infections (Asante et al., 2020, Perez et al., 2020). Notably, their acquisition 
of methicillin resistance, mediated by mecA gene (encoding alternative form of penicillin-




and that comes at increased cost in lower-middle-income countries (Asante et al., 2020, Asante 
et al., 2019).  
CoNS (including Staphylococcus epidermidis, S. haemolyticus and S. saprophyticus) are 
increasingly implicated in significant infections, including urinary tract infections, 
endocarditis, surgical site infections, and prosthetic joint infections (Becker et al., 2014, Rogers 
et al., 2009). They are frequently associated with bacteremia in patients habouring central and 
peripheral venous catheters, orthopaedic prostheses, pacemakers and infections involving 
biofilm formation on inserted biomaterials (Asante et al., 2020, Becker et al., 2014, García et 
al., 2004). Biofilm formation, which facilitates the adherence of CoNS to surfaces of 
biomaterials and host tissues, is one of the main virulence mechanisms deployed by CoNS to 
establish infection. Biofilms play the function of providing a protective barrier against 
antibiotics and to evade the immune response (Goetz et al., 2017).  
Studies characterising CoNS, including their virulence and resistance mechanisms in South 
Africa, are relatively few, especially in clinical settings with scanty descriptions of their 
molecular epidemiology. Even fewer are the number of studies that have conducted whole-
genome sequencing (WGS) studies into clinical CoNS isolates. This study thus describes the 
genomic profile of CoNS species obtained from hospitals within the KwaZulu-Natal Province 
in South Africa, using WGS and bioinformatics analysis to help fill the information gap.  
2.0 Literature review 
This section provides a brief overview of the literature on antibiotic resistance, the 
epidemiology of resistance genes, the molecular mechanisms of resistance in Gram-positive 
bacteria, CoNS and the role of WGS and bioinformatics analysis in antimicrobial resistance 
(AMR) research. The literature review is further elaborated in Chapter Two in the form of a 




Staphylococci in Africa,” published in Microbial Drug Resistance. This review article 
discusses studies from Africa where CoNS species were suspected as the cause of various 
infections, focusing on identification/laboratory detection, their clinical relevance, 
transmission, antibiotic susceptibility, typing, and treatment. 
2.1 The threat of antibiotic resistance 
The discovery and subsequent improvements of antibiotics in the 20th century gave a 
significant boost to the fight against infectious diseases, revolutionizing the therapy of 
infectious diseases and improving health and quality of life through the prevention and 
treatment of infectious diseases (Asante and Osei Sekyere, 2019). Indeed, so bright were the 
prospects that it led to the thinking that premature death due to infectious agents would be 
confined to the past. However, the introduction of antibiotics into clinical practice has been 
associated with the selection of antibiotic-resistant strains, thus rendering the drugs 
progressively ineffective in treating several infections (Brown and Wright, 2016, Osei Sekyere 
and Asante, 2018).  
The ability of bacteria to resist the effects of antibiotics that they were previously susceptible 
to, is called antibiotic resistance (Davies and Davies, 2010). The ability of resistant bacteria to 
share resistance genes with susceptible bacteria, thereby making them also resistant, 
contributes to the spread of antibiotic resistance in a given niche. It is estimated that mortality 
due to AMR will reach 10 million by the year 2050 if measures are not put in place to stem the 
tide (O’Neill, 2014). 
Microorganisms can evolve through epigenetic mechanisms and genetic variations in response 
to selection pressure. Antimicrobial resistance (AMR) continues to compromise the effective 
prevention and treatment of several infections caused by bacteria, fungi, viruses, and parasites, 




(Brown and Wright, 2016, Osei Sekyere and Asante, 2018). A surge in the global morbidity 
and mortality as a result of infectious diseases has occurred partly due to antimicrobial 
resistance (Brown and Wright, 2016).  
There are documented reports of resistance to all known antibiotics currently in use, including 
reserve antibiotics such as tigecycline, vancomycin, carbapenems, ceftaroline and colistin 
(Osei Sekyere, 2016, World Health Organization, 2017). This leaves clinicians with severely 
reduced options in treating infectious diseases, especially those caused by multidrug-resistant 
pathogens. It is thus imperative to safeguard the use of antibiotics to preserve the already 
limited options available as the development of new antibiotics has stalled over the past 30 
years (Asante and Osei Sekyere, 2019, Brown and Wright, 2016).  
2.2 Known mechanisms of antibiotic resistance 
Antibiotic resistance in bacteria can be intrinsically expressed or may be acquired. Soil bacteria 
are known to produce antibiotics to ward off natural competition from neighbouring bacterial 
species (Pehrsson et al., 2013). These bacteria usually develop resistance to protect them 
against the antibiotics produced by themselves, as do the neighbouring bacteria to escape the 
effects of the naturally produced antibiotics (Asante and Osei Sekyere, 2019). The resistance 
mechanisms developed, as a result, can be transferred to other non-resistant bacteria through 
mobile genetic elements (MGEs) such as plasmids, transposons, integrons, integrative and 
conjugative elements, insertion sequence common regions and gene cassettes. This process, 
referred to as horizontal gene transfer (HGT), helps to facilitate the spread of antibiotic 
resistance genes in bacteria (Stokes and Gillings, 2011).  
Intrinsic resistance refers to the innate ability of bacteria to resist the effects of an antimicrobial 
agent through its innate functional or structural characteristics, without the need for mutation 




microbes are inhibited/killed, leaving the resistant ones to proliferate. This allows for the 
predominance of resistant bacteria within a given niche. Selection pressure is exerted by any 
condition that allows bacteria with intrinsic or acquired resistance to survive and multiply 
(Holmes et al., 2016). Generally, bacteria mediate intrinsic resistance by two major 
mechanisms, i.e., by membrane impermeability and inaccessibility, and extrusion of antibiotics 
through chromosomally-encoded efflux pumps. For example, due to their thin peptidoglycan 
layer and extra lipopolysaccharide-containing outer membrane, Gram-negative bacteria are 
resistant to the glycopeptide vancomycin, which is too large a molecule to enter the cell. As 
well, in some intrinsically resistant bacteria, the porin size and chemical properties restrict the 
entry of certain antibiotics (Cag et al., 2016).  
Bacteria have well-differentiated mechanisms by which they evade and develop resistance to 
antibiotics. Generally, bacteria elude the effects of antibiotics by three primary mechanisms, 
which usually function synchronously with one another (Cag et al., 2016). These mechanisms 
include inactivation of the drug by enzymes such as β-lactamases and 
aminoglycoside/fluoroquinolone acetyltransferases; target modification as is the case with 
DNA gyrase and topoisomerase for fluoroquinolone resistance and decreased uptake of the 
drug through efflux upregulation and porin downregulation (Cag et al., 2016).  
Enzymatic inactivation of drugs is observed in β-lactams, where β-lactamases can bind to and 
inactivate them. When β-lactams are hydrolysed, they form open rings that are ineffective in 
binding to their target, penicillin-binding proteins (PBPs) (Cag et al., 2016). Other enzymes, in 
contrast to β-lactamases, alter antibiotics by adding chemical groups that decrease antibiotics’ 
affinity to their target molecules. For example, the antibiotic chloramphenicol may be altered 
by the enzyme chloramphenicol acetyltransferase (CAT), which changes chloramphenicol to 
an inactive mono- or diacetate form (Zienkiewicz et al., 2017). Resistance to aminoglycosides 




modifying enzymes (AMEs), which can acetylate, phosphorylate, or adenylylate the drug. 
AMEs inactivate aminoglycosides by mimicking their RNA targets and replacing them (Chee-
Sanford et al., 2009, Davies and Davies, 2010).  
Bacteria can replace or modify molecules targeted by antibiotics, making the drug molecules 
unable to bind to their intended target, thus evading the biocidal/biostatic effects of antibiotics 
(Cag et al., 2016). Such mechanisms are observed in quinolones, macrolides, polymyxins and 
β-lactams. Notably, bacteria develop resistance to β-lactams by altering their primary targets, 
PBPs (Asante et al., 2019). Quinolone resistance may occur as a result of modifications to DNA 
gyrase (Gyr A) (Liu et al., 2012), while the activity of macrolides may be stifled by the 
methylation of its target site viz., the 23s rRNA (Asante et al., 2019). Resistance to 
vancomycin, which for a long time was considered the agent “of last resort” for MRSA 
infections, may occur through modifications in the drug target D-Ala–D-Ala terminus of 
peptidoglycan, allowing for bacterial cell wall synthesis even in the presence of vancomycin 
(Cui et al., 2003, Cui et al., 2006).  
Bacteria may prevent the buildup of antibiotics on their target molecules by reducing drug 
absorption into cells, increasing drug expulsion from the cell, or by utilizing both mechanisms 
concurrently (Delcour, 2009). Efflux mechanisms actively pump out antibiotics from within 
the cell to prevent their accumulation or interaction with their target-site molecule(s) (Osei 
Sekyere et al., 2016). Efflux molecules may work in concert with porin modifications to 
intensify the expulsion of antibiotics from within the bacterial cell.  Porins are bacterial cell 






2.3 Epidemiology of resistance genes and molecular mechanisms of resistance in Gram-
positive bacteria 
The first report of resistance in penicillin to a penicillin-inactivating enzyme, even before it 
became available clinically (Abraham and Chain, 1940), signaled a severe setback in 
antimicrobial chemotherapy. Resistance to all classes of antibiotics has been observed in 
clinically relevant bacteria, including resistance to aminoglycosides (gentamicin, tobramycin, 
amikacin, streptomycin), β-lactams (penicillins, cephalosporins, carbapenems, monobactams, 
cephems), quinolones (nalidixic acid and later generations of fluoroquinolones), glycopeptides 
(vancomycin, teicoplanin), sulphonamides, trimethoprim, rifampicin, tetracyclines 
(tetracycline, doxycycline, minocycline, oxytetracycline) polymyxins (colistin, polymyxin B), 
phenicols (chloramphenicol, thiamphenicol, florfenicol), glycylcyclines (tigecycline), and 
macrolides (azithromycin, erythromycin). This observed resistance has resulted from the use 
of these antibiotics in the clinical, veterinary and agricultural settings (Hancock, 2005, 
Laxminarayan et al., 2013).  
Resistance to β-lactams among Gram-positive bacteria arises through mutations in PBPs and 
other non-PBP related genes. These kinds of mutations and changes in PBPs decrease the 
affinity of PBPs for β-lactam antibiotics, including the anti-Gram-positive cephalosporins 
(Asante et al., 2019, Odonkor et al., 2012). For instance, when methicillin-susceptible 
Staphylococcus aureus strains acquire the mecA gene, which encodes penicillin-binding 
protein 2a (PBP 2a), they become methicillin resistant. PBP 2a is different from the usual 
penicillin-binding proteins and does not bind to methicillin or other β-lactam antibiotics at its 
active site (Amoako et al., 2019b, Asante et al., 2019). The mecA gene is borne on the mobile 
element referred to as the staphylococcal cassette chromosome SCCmec in staphylococci. 




MGEs such as SCCmec in staphylococci and plasmid-borne PBP in enterococci, pneumococci 
and streptococci (Amoako et al., 2019a, Asante et al., 2019).  
In both Gram-positive and Gram-negative bacteria, resistance to tetracyclines, 
fluoroquinolones and aminoglycosides are transferred by plasmids bearing integron- and 
transposon-mobilised resistance genes (Cag et al., 2016). In Gram-positive bacteria, however, 
resistance to fluoroquinolones is mainly due to chromosomal mutations in topoisomerase genes 
(grlA and grlB) and gyrase genes (gyrA and gyrB) and overexpression of efflux pumps, as seen 
in NorA efflux pump and its related counterpart, pmrA, which mediate resistance to 
fluoroquinolones in S. aureus and S. pneumonia respectively (Berger-Bächi, 2002).  
Generally, resistance to newer agents such as glycylcyclines (tigecycline), oxazolidinones 
(linezolid), lipopeptides (daptomycin), ramoplanin, ketolides (telithromycin), streptogramins 
(quinupristin/dalfopristin), ceftaroline, telavancin, diphenyl glycopeptides (oritavancin and 
dalbavancin) and the older cationic antimicrobial peptides (polymyxins) is minimal and limited 
to isolated cases in parts of the globe (Hancock, 2005, Osei Sekyere, 2016). Indeed, most of 
these newer agents are very effective against resistant/difficult-to-treat Gram-positive related 
infections such as MRSA and vancomycin-resistant Enterococci (VREs). Thus, there are more 
reserve treatment options for recalcitrant Gram-positive related infections than Gram-negative 
ones (Hancock, 2005).  
2.4 Staphylococcus species and CoNS 
The term staphylococcus was first described in 1883 by Ogston, for the micrococci group 
causing pus formation and inflammation (Sugawara and Nikaido, 2014). Staphylococcus 
species are spherical bacteria that can occur singly, in pairs, tetrads, or more commonly in 
grapelike clusters. They are Gram-positive cocci ranging in diameter from 0.5-1µm. 




facultative anaerobic bacteria, able to survive under diverse conditions on environmental 
surfaces. They are regular inhabitants of the skin, skin glands and mucous membranes, 
especially the nasal cavities. Moreover, they can be found symbiotically in the mouth, 
intestines, upper respiratory and genitourinary tracts. However, they can assume pathogenic 
roles when they gain access to other sites within the body through broken skin and mucosal 
membranes (Fontana and Favaro, 2018).  
Staphylococci (especially S. aureus) may cause mild local infections of the skin such as 
impetigo, furunculosis and cellulitis. If left untreated, these infections can proceed to life-
threatening infections such as osteomyelitis, bacteremia, meningitis, scalded skin syndrome, 
pneumonia, and encephalitis by spreading to various organs through blood vessels and 
neighbouring tissues (Fontana and Favaro, 2018). Owing to its ability to produce many 
virulence and pathogenic determinants, S. aureus is the most pathogenic among the 
staphylococci species (Bien et al., 2011). Staphylococci possess a vast arsenal of virulence 
genes, which may be species- or strain-specific, facilitating adherence to surfaces, persistence, 
colonisation, invasion, toxicity, and evasion of the intrinsic and adaptive immune response 
(Becker et al., 2014).  
Generally, compared with S. aureus, the virulence of CoNS is under-researched, save for 
biofilm formation by S. epidermidis (Becker et al., 2014). Biofilm-associated infections, 
including those caused by CoNS, are highly resistant to antibiotics due to slime production, 
with biofilm-producing strains about 1000-fold more resistant than their planktonic 
counterparts (Fontana and Favaro, 2018).  
CoNS such as S. epidermidis, S. haemolyticus and S. saprophyticus are of concern as 




its ability to cause purulent infections (Fontana and Favaro, 2018). The epidemiology and 
clinical relevance of CoNS have been discussed extensively in chapter 2 of this thesis. 
In summary, staphylococci are cause for concern both as community and nosocomial 
pathogens, with an emerging role in human and animal diseases, requiring the attention of 
microbiologists and clinicians. There is a paucity of information on the molecular 
epidemiology of drug-resistant CoNS in South Africa and Africa. Furthermore, studies 
involving the use of WGS on CoNS isolates are rare in Africa, thus creating an information 
gap on the molecular mechanisms of resistance and virulence, their mobilisation through MGEs 
as well as strain types and phylogenies. This study provides a perspective from Northdale, 
Edendale and Grey’s hospitals in the uMgungundlovu District in the KwaZulu-Natal Province 
in South Africa.  
3.0 Aim  
To describe the molecular epidemiology, phenotypes and genotypes of coagulase-negative 
staphylococci clinical isolates from uMgungundlovu District, KwaZulu-Natal (KZN), South 
Africa.  
3.1 Specific objectives 
1. To ascertain the incidence of CoNS from hospitals in the uMgungudlovu District of the 
KwaZulu-Natal Province from blood cultures routinely processed by the central 
microbiology laboratory using culture and biochemical techniques. 
2. To speciate the CoNS using the automated VITEK 2 system. 
3. To determine the susceptibility profile of CoNS isolates against a CLSI-recommended 
antibiotic panel using the Kirby-Bauer disk-diffusion and MIC (broth microdilution) 
methods as appropriate for the antibiotics: penicillin G, cefoxitin, ceftaroline, 




chloramphenicol, tetracycline, doxycycline, teicoplanin, tigecycline, linezolid, 
clindamycin, rifampicin, sulphamethoxazole/trimethoprim, nitrofurantoin and 
vancomycin. 
4. To determine the ability of CoNS isolates to form biofilm using the quantitative (tissue 
culture plate) method. 
5. To describe the clinical and epidemiological relevance of CoNS by way of a literature 
review. 
6. To identify and characterize antibiotic-resistance and virulence genes in CoNS, their 
associated MGEs and their genetic support/environment using whole genome 
sequencing and bioinformatics tools such as ResFinder, Comprehensive Antibiotic 
Resistance Database (CARD), VirulenceFinder, virulence factor database (VFDB), 
BacWGSTdb, Rapid Annotation using Subsystem Technology (RAST), 
SCCmecFinder, PlasmidFinder and MobileElementFinder. 
7. To determine the clonal relatedness and phylogeny of isolates using whole-genome 
sequencing and bioinformatics tools such as CSIPhylogeny, Figtree and Phandango to 
compare and contrast study strains with others. 
 
4.0 Synopsis of methodology 
4.1 Ethical considerations 
The study was approved by the Biomedical Research Ethics Committee of the University of 
KwaZulu-Natal (Reference: BREC/00001302/2020) as a sub-study of the overarching research 
programme on Antibiotic Resistance and One Health (Reference: BCA444/16). The study was 
originally envisaged as a comparison between pig and clinical isolates as part of the 




the Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) project 
and the National Health Laboratory Service (NHLS) was asked to collect and store CoNS 
isolates while an application to expand the bacterial species investigated in the overarching 
research programme from S. aureus only to Staphylococcus spp. was made to BREC. Very few 
CoNS samples were recovered from the study on pigs, precluding comparison. The study thus 
took a purely clinical focus investigating the molecular epidemiology of CoNS from hospitals 
in the uMgungundlovu district.  
4.2 General methodology 
The study describes the molecular epidemiology, phenotypic and genotypic characteristics of 
CoNS isolated from hospitals in the uMgungundlovu district of the KwaZulu-Natal Province, 
South Africa. Presumptive CoNS isolates (from blood cultures) were obtained from routine 
blood cultures processed by central microbiology laboratory that receives samples from 
hospitals in the district. Isolates were collected over five months from October 2019 to 
February 2020 by the central laboratory and stored in the Antimicrobial Research Unit at the 
University of KwaZulu-Natal. Isolates were initially characterised and identified by culture and 
biochemical tests and speciated using the automated VITEK 2 system (BioMérieux, Marcy-
L’Etoile, France). Coagulase activity or its absence was determined using the Staphaurex™ 
Latex Agglutination Test and polymerase chain reaction (PCR) determination of mecA gene 
was used to confirm methicillin resistance. The antibiotic susceptibility profiles of isolates were 
determined using the Kirby-Bauer disk-diffusion method against a panel of 20 antibiotics. The 
biofilm-forming ability of CoNS isolates was quantitatively determined using the tissue culture 




The resistome, virulome, mobilome, clonality and phylogeny of circulating CoNS clones were 
ascertained using WGS and bioinformatic tools. Comparative genomics of CoNS was done to 
assess dominant endemic clones spreading in the hospital setting. 
5.0  Outline of the thesis 
This study is presented in the form of journal articles and manuscripts and comprises 
the following five chapters: 
 Chapter 2. Manuscript 1: Review of Clinically and Epidemiologically Relevant 
Coagulase-Negative Staphylococci in Africa. Microbial Drug Resistance, 
February 2019; https://www.liebertpub.com/doi/10.1089/mdr.2019.0381. This 
review discusses studies from Africa where CoNS species were suspected as the 
cause of various infections, focusing on identification/laboratory detection, their 
clinical relevance, transmission, antibiotic susceptibility, typing, and treatment.  
 Chapter 3. Manuscript 2: Multidrug-resistant coagulase-negative 
staphylococci from the uMgungundlovu District of KwaZulu-Natal Province in 
South Africa: Emerging Pathogens. This manuscript, submitted to the Journal 
Antibiotics, describes the types and susceptibility profiles of clinical CoNS 
isolates in the KZN Province in South Africa. 
 Chapter 4. Manuscript 3: Genomic analysis of multidrug-resistant 
Staphylococcus epidermidis isolates from clinical sources in the KwaZulu-Natal 
Province, South Africa. This manuscript submitted to Frontiers Microbiology, 
describes the antibiotic resistome, mobilome, virulome and phylogenic analysis 
of clinical methicillin-resistant Staphylococcus epidermidis in the KwaZulu-




 Chapter 5. Conclusion. This chapter provides a summary of the work and the 
significance thereof and includes limitations of the study and recommendations 
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Coagulase-negative staphylococci (CoNS) are increasingly associated with nosocomial 
infections, especially among the immunocompromised and those with invasive medical 
devices, posing a significant concern. We report on clinical multidrug-resistant CoNS from the 
uMgungundlovu District of KwaZulu-Natal Province in South Africa as emerging pathogens. 
One hundred and thirty presumptive CoNS from blood culture CoNS isolates constituted the 
sample. Culture, biochemical tests and the Staphaurex™ Latex Agglutination Test were used 
for the initial identification of CoNS isolates, while confirmation and speciation were 
undertaken by the VITEK 2 system. Susceptibilities of isolates against a panel of 20 antibiotics 
were determined using the Kirby-Bauer disk-diffusion method and the multiple antibiotic 
resistance (MAR) indices of the isolates were determined. The polymerase chain reaction 
(PCR) was used to amplify the mecA gene to confirm methicillin resistance.   
Overall, 89 out of the 130 presumptive CoNS isolates were confirmed as CoNS by the VITEK 
2 system. Of this number, 68 (76.4%) isolates were putatively methicillin-resistant by the 
phenotypic cefoxitin screen test, of which 63 (92.6%) were confirmed by detection of the mecA 
gene. Staphylococcus epidermidis (19.1%), S. hominis ssp hominis (15.7%), and S. 
haemolyticus (16.9%) were the most common CoNS species. Isolates showed high levels of 
resistance against penicillin (100.0%), erythromycin (74.2%) and azithromycin (74.2%), while 
displaying high susceptibilities to linezolid (95.5%), gentamicin (95.5%), and tigecycline 
(94.4%). Multidrug resistance was observed in 76.4% of isolates. MAR index calculation 
revealed 71.9% with MAR index > 0.2 and 20.2% > 0.5. Isolates with the highest MAR indices 
(0.7 and 0.8) were recovered from the neonatal intensive care unit. Fifty-one MDR 




The high prevalence of methicillin resistance and multidrug resistance in several species of 
CoNS necessitates surveillance of this emerging pathogen, currently considered a contaminant 
of microbial cultures.   
Keywords: Coagulase-negative staphylococci, antibiotic resistance, multidrug resistance, 
infections, multiple antibiotic resistance index.  
Running title: Coagulase-negative staphylococci in South Africa.  
 
1.0 INTRODUCTION 
Staphylococci are classified as either coagulase-positive or coagulase-negative, depending on 
their ability to clot plasma that is facilitated by the enzyme coagulase (Gómez-Sanz et al., 
2019). Coagulase-negative staphylococci (CoNS) are the most frequent colonisers of the skin 
and mucous membranes and the most frequently isolated organisms in microbiology 
laboratories (Asante et al., 2020). Although CoNS are mostly considered contaminants in 
clinical specimens, they have been implicated in clinically relevant infections, including 
urinary tract infections, endocarditis, bloodstream infections (including neonatal sepsis) and 
foreign body-related infections (Asante et al., 2020). The skin and mucous membranes of the 
host, which are home to an abundance of CoNS species, are significant sources of endogenous 
CoNS infections, facilitated by transmission through medical procedures (Becker et al., 2014). 
Pathogenic CoNS are usually associated with clinical environments and found in 
immunocompromised patients as well as in patients with indwelling metallic or polymer 
devices, such as orthopaedic prostheses, peripheral venous catheters and artificial pacemakers 
but are less commonly involved in community-associated diseases (David and Elliott, 2015, 




pathogens implicated in nosocomial bloodstream infections, responsible for 30-40% of these 
infections (David and Elliott, 2015). A review found a CoNS prevalence of 6-68% in suspected 
human infections in Africa within the last decade (Asante et al., 2020). Of the CoNS, S. 
epidermidis is the most common cause of human infection, culpable for about 24-80% of these 
infections (Becker et al., 2014).  
CoNS are noted for their ability to develop antibiotic resistance against commonly used 
antibiotic classes such as β-lactams, aminoglycosides and macrolides, with particularly high 
reported methicillin resistance rates (Asante et al., 2020) as well as resistance to antibiotics of 
last resort such as the glycopeptides (May et al., 2014). Antibiotic resistance genes conferring 
resistance to these antibiotic classes can be transferred between staphylococcal species such as 
S. aureus and S. intermedius, limiting the therapeutic options available (Gómez-Sanz et al., 
2019). 
This study describes the incidence of MDR CoNS from three hospitals in the uMgungundlovu 
District in the KwaZulu-Natal Province in South Africa.  
2.0 MATERIALS AND METHODS 
2.1 ETHICAL CONSIDERATIONS  
The study was approved by the Biomedical Research Ethics Committee of the University of 
KwaZulu-Natal (Reference: BREC/00001302/2020). This study was a sub-study of the 







2.2 STUDY SETTING, SAMPLE COLLECTION AND IDENTIFICATION  
A total of one hundred and thirty (130) suspected staphylococcal isolates recovered from 
routine clinical specimens processed by the central microbiology laboratory for 
uMgungundlovu district over the period October 2019 and February 2020 constituted the 
sample. Isolates were obtained from blood cultures from both outpatients and inpatients, the 
latter from the intensive care unit (ICU), neonatal intensive care unit (NICU), paediatric ward, 
paediatric outpatient department (OPD), emergency departments, surgical ward and nursery.  
Presumptive identification was undertaken by Gram staining, colony morphology on blood 
agar and the catalase test. The Staphaurex™ Latex Agglutination Test (Thermo Scientific, 
Kent, UK) was used to differentiate staphylococci based on their coagulase activity. Speciation 
was undertaken using the automated VITEK 2 system (BioMérieux, Marcy-L’Etoile, France). 
Demographic data of patients (age, sex, ward type, and specimen source) were obtained from 
anonymous patient records. Isolates were stored at -86°C in tryptic soy broth (Basingstoke, 
Hampshire, England) containing 10% glycerol (VWR Lifescience Biotechnology, USA) and 
used for further analyses.  
2.3 ANTIMICROBIAL SUSCEPTIBILITY TESTING AND DETERMINATION OF 
METHICILLIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCI 
(MRCONS)   
Antibacterial susceptibility profile of isolates against a selected antibiotic panel was ascertained 
by the Kirby-Bauer disk-diffusion method and interpreted according to the Clinical and 
Laboratory Standard Institute (CLSI) (Clinical and Laboratory Standards Institute, 2016) 
guidelines using the following antibiotic discs; penicillin G (10 µg), cefoxitin (30 µg), 
ceftaroline (30 µg), ciprofloxacin (5 µg), moxifloxacin (5 µg), azithromycin (15 µg), 




tetracycline (30 µg), doxycycline (30 µg), teicoplanin (30 µg), tigecycline (15 µg), linezolid 
(30 µg), clindamycin (10 µg), rifampicin (5 µg), sulphamethoxazole/trimethoprim (1.25/23.75 
µg) and nitrofurantoin (300 µg). The cefoxitin test (disc diffusion) was used to screen 
methicillin resistance (Clinical and Laboratory Standards Institute, 2016). All discs were 
purchased from Oxoid (Oxoid Ltd, Hampshire, UK). Multidrug resistance was defined as 
resistance to at least one agent in three or more distinct antibiotic drug classes. Susceptibility 
testing for vancomycin was done by minimum inhibitory concentration (MIC) (according to 
the CLSI guidelines) using the broth microdilution method due to the absence of breakpoints 
for the disc diffusion method (Clinical and Laboratory Standards Institute, 2016). 
Staphylococcus aureus ATCC 25923 and Staphylococcus epidermidis ATCC 12228 were used 
as the control strains. The multiple antibiotic resistance (MAR) index was calculated using the 
formula; MAR=x/y, where x is the number of antibiotics an isolate displayed resistance 
towards and y is the total number of antibiotics tested against the isolate. The MAR index was 
used as an indicator of health risk assessment to identify if isolates originate from environments 
of high or low antibiotic use. 
2.4 DNA EXTRACTION AND PCR AMPLIFICATION OF MecA  
Genomic DNA was extracted using the GeneJET Genomic DNA Purification Kit (Thermo 
Fisher Scientific Baltics, Vilnius, Lithuania) according to the manufacturer’s instructions. The 
purity and concentration of extracted DNA were determined by Nanodrop™ 1000 
spectrophotometer (Thermo Scientific, Wilmington, Delaware, USA) and stored at -20°C for 
PCR. PCR detection of the mecA gene was done for presumptive methicillin-resistant 
coagulase-negative staphylococci (MRCoNS) isolates. The mecA gene, conferring resistance 
to methicillin, was amplified using the T100™ Thermal cycler (Bio-Rad, California, USA), 




ATTGCTGTTAATATTTTTTGAGTTGAA (Inqaba Biotech, Pretoria, South Africa) 
(Martineau et al., 2000), generating a 174 base pair fragment (Asante et al., 2019).  
PCR was performed in a 25 µl reaction mixture containing 12.5 µl DreamTaq Green PCR 
Master Mix (ThermoScientific, California, USA), 0.5 µl each of forward and reverse primers, 
and 3 µl of template DNA. The PCR protocol was denaturation at 94°C for 5 min; 35 cycles of 
94°C for 30s; 55°C for 45 s and 72°C for 45 s; and a final extension step of 10 min at 72°C. 
PCR products were run on 1.5% agarose gel at 120V for 60 min in a 1X Tris-acetate-EDTA 
(TAE) buffer (BioConcept Ltd, Basel, Switzerland) and visualised by UV transillumination 
using Bio-Rad ChemiDoc™ MP System (Bio-Rad, California, USA). S. aureus ATCC 43300 
was used as the positive control. 
2.5 STATISTICAL ANALYSIS  
Statistical analysis was carried out using Microsoft Excel 2016 and IBM SPSS 26. Possible 
relationships between variables were investigated using the Pearson Chi-Square test and one-
way analysis of variance (ANOVA). A P-value of < 0.05 was considered statistically 
significant.  
3.0 RESULTS 
3.1 ISOLATION, IDENTIFICATION AND SPECIES DISTRIBUTION 
Eighty-nine (89) out of the 130 presumptive isolates were confirmed as CoNS by the automated 
VITEK 2 system and used for further analysis. Of these, Staphylococcus epidermidis, 17 
(19.1%) was the most frequent species identified. Identities of other CoNS isolates were: S. 
hominis ssp hominis, 14 (15.7%), S. haemolyticus, 15 (16.9%), and S. lentus, 13 (14.6%) (Fig 
1). Of the remaining 41 non-CoNS isolates, Enterococcus faecalis (12), Enterococcus faecium 




Leuconostoc mesenteroides ssp cremoris (5), Enterococcus columbae (1) and Dermacoccus 
nishinomiyaensis (1).  
3.2 ANTIBIOTIC RESISTANCE PHENOTYPIC PATTERNS OF CONS AND MecA 
DETECTION 
Of the 89 isolates, 68 (76.4%) were putatively methicillin-resistant by the phenotypic cefoxitin 
screen test. All isolates displayed resistance to at least one agent in one antibiotic class. High 
levels of antibiotic resistance rates were recorded for penicillin (100.0%), erythromycin 
(74.2%), azithromycin (74.2%), cefoxitin (76.4%), and trimethoprim/sulphamethoxazole 
(68.5%). Isolates were highly susceptible to linezolid (95.5%), gentamicin (95.5%), tigecycline 
(94.4%), nitrofurantoin (92.1%), amikacin (89.9%), vancomycin (86.5%), teicoplanin (82.0%), 
and ceftaroline (76.4%). Generally, MRCoNS isolates displayed higher resistance against most 
antibiotics. Furthermore, MRCoNS showed somewhat reduced susceptibilities of 95.6%, 
94.1%, 94.1%, 92.6%, 89.7%, 86.8% and 73.5% against linezolid, tigecycline, gentamicin, 
nitrofurantoin, amikacin, teicoplanin and ceftaroline, respectively. The detailed phenotypic and 
genotypic profile of isolates is available in the supplementary Table S1. Table 1 delineates the 
percentage resistance of all CoNS and MRCoNS isolates to the different antibiotics tested. 
None of the isolates were resistant to all antibiotics tested. Sixty-three (92.6%) of the 68 
MRCoNS by cefoxitin phenotypic test were confirmed as MRCoNS by PCR detection of the 
mecA gene.  
3.3 MULTIDRUG RESISTANCE AND MULTIPLE ANTIBIOTIC RESISTANCE 
(MAR) INDEX  
The MAR index ranged from 0.05 to 0.80, with an overall mean of 0.34 (Tables 2 and 3). 
Multidrug resistance was observed in 68 (76.4%) of the isolates. Fifty-one antibiograms were 




3.4 DEMOGRAPHIC CHARACTERISTICS OF PATIENTS AND STATISTICAL 
ANALYSIS 
Patients' ages ranged from 0 to 77 years, with the mean age being 17.19 ± 24.33 years. More 
than half (50.6%) of isolates were obtained from patients who were less than one year old. 
Isolates were obtained from 46 (51.7%) males and 33 (37.1%) females, while 7 (7.9%) were 
unknown/unspecified. Outpatients and inpatients made up 19.1% and 80.9% of samples, 
respectively. The distribution of isolates by wards was as follows; paediatric ward (17.9%), 
Nursery (6.7%), emergency unit (5.7%), ICU (13.5%), medical ward (11.2%), surgical ward 
(6.7%), extension ward (7.9%), obstetrics and gynaecology ward (1.1%), and maternity ward 
(1.1%). The Pearson Chi-Square test showed no significant association between the ward type 
and MAR index: X2(104, N=89) =116.05, P=0.197), even though the isolates with the highest 
MAR indices were from the ICU (Fig 2). Also, there was no statistically significant association 
between CoNS species and MAR index; X2(182, N=89) =203.07, P=0.136). Furthermore, even 
though one-way ANOVA showed that S. saprophyticus isolates had a higher MAR mean 
(p=0.012), the effect size was small (0.201).  
 
4.0 DISCUSSION 
This study describes the species distribution, antibiotic resistance profiles, MDR and the MAR 
indices of clinical CoNS isolates from hospitals in the uMgungundlovu District of KwaZulu-
Natal Province in South Africa. There was a diversity of CoNS species isolated, with S. 
epidermidis as the most abundant species, in agreement with previous studies conducted in 
ICUs that investigated vancomycin heteroresistance and reduced glycopeptide susceptibility 
among bloodstream CoNS in Egypt and Italy (Mashaly and El-Mahdy, 2017, Natoli et al., 




from clinical samples in healthcare settings in Nigeria (46.3%) (Ibadin et al., 2017) and Egypt 
(75.9%) (Mashaly and El-Mahdy, 2017). However, higher MRCoNS prevalence figures of 
86% (Ballot et al., 2012) and 100% (Ehlers et al., 2018) were detected for CoNS implicated in 
infections in South Africa.  The S. epidermidis group (S. epidermidis and S. haemolyticus) are 
important causes of nosocomial infections (Gómez-Sanz et al., 2019). S. epidermidis is the 
most frequently isolated staphylococcal species in humans and considered the most important 
CoNS species (Becker et al., 2014). In this study, the S. epidermidis group was part of the three 
most abundant CoNS species.  
There was a 92.6% agreement between phenotypic and genotypic confirmation of methicillin 
resistance in this study. Methicillin resistance in isolates that lack the mecA gene may be 
mediated by other mechanisms of methicillin resistance, such as possession of mecC (Dhaouadi 
et al., 2019), mecB genes (Becker et al., 2018), or the overproduction of β-lactamases (Asante 
et al., 2020). The development of methicillin resistance has been observed in about 80% of 
CoNS species, contributing to increased morbidity and mortality in hospitals due to their 
prominence in healthcare-associated infections (HAIs) (Ibadin et al., 2017).  
The majority (76.4%) of the isolates in this study showed a multidrug resistance phenotype, 
with isolates displaying high resistance to commonly used antibiotics such as penicillin 
(100.0%), macrolides (74.2% each for erythromycin and azithromycin), and 
sulphamethoxazole/trimethoprim (68.5%). Similar high resistance patterns have been observed 
against these antibiotics in other studies elsewhere (Adeyemi et al., 2010, Klingenberg et al., 
2007). They, however, displayed high susceptibility against reserve antibiotics such as 
linezolid (95.5%) and the anti-MRSA β-lactam antibiotic ceftaroline (76.4%). Similarly, 
complete susceptibility of CoNS isolates was observed against vancomycin, tigecycline, 
teicoplanin and linezolid in another South Africa study (Ehlers et al., 2018). The high 




antibiotics, mainly for resistant staphylococcal infections. Thus, the last resort antibiotics still 
retain high activity against CoNS and can be used for empirical treatment of conditions such 
as suspected CoNS sepsis, even though resistance against these antibiotics is gradually 
increasing (Asante et al., 2020). Due to its ability to penetrate biofilm, rifampicin is one of the 
preferred antibiotics for treating bone and joint infections (Nicolosi et al., 2020). However, the 
development of resistance due to continued use of the antibiotic has necessitated its use in 
combination with other antibiotics in the treatment of bone and joint infections (Nicolosi et al., 
2020). The resistance to rifampicin observed in this study (42.7%) means that the drug may not 
be relied upon alone in treating infections caused by CoNS.   
Taking into consideration their susceptibility profiles, it can be stated that vancomycin, 
nitrofurantoin, linezolid, tigecycline, teicoplanin, gentamicin, amikacin, and the anti-MRSA 
cephalosporin ceftaroline retain high activities against CoNS in the study setting and may be 
relied upon in the treatment of CoNS infections. Decreasing vancomycin susceptibility is 
reported with increasing frequency in the clinically relevant CoNS literature and may be 
associated with increased vancomycin exposure (Center et al., 2003). The current study 
recorded 13.5% CoNS isolates with intermediate susceptibility to vancomycin. It is imperative 
to mitigate the development of vancomycin non-susceptibility, considering the vital role of 
glycopeptides in the treatment of resistant infections.  
Multidrug resistance (MDR) in CoNS is problematic in low/middle-income countries due to 
the limited access to newer antibiotics and the high cost of alternative treatment (Asante et al., 
2020). Not surprisingly, MRCoNS isolates displayed higher antibiotic resistance compared to 
methicillin-susceptible CoNS (MSCoNS), as methicillin resistance has been shown to co-select 
for resistance to other antibiotics (Asante et al., 2020, Pyörälä and Taponen, 2009). The study 
showed that the majority of isolates were multidrug resistant, with 71.9% of isolates having 




recorded high MDR rates of CoNS (Ibadin et al., 2017). MAR values higher than 0.2 are 
indicative of isolates, possibly originating from environments where antibiotics are frequently 
used and may also hint at possible nosocomial transmission within the hospital setting (Paul et 
al., 1997).  
There was no statistically significant association between the type of ward and the MAR index 
(P=0.197), even though some isolates with high MAR indices were recovered in the neonatal 
ICU.  
Considering that CoNS are recognised neonatal pathogens in upper and high-income countries, 
they ought to be given equal attention in low- and middle-income countries (Patel and Saiman, 
2010). That the ICU had the highest number of recovered isolates is significant as CoNS are 
frequently isolated in bloodstream infections in ICU patients (Asante et al., 2020). The use of 
invasive devices such as catheters, commonly used in ICUs, increases the risk of infection by 
CoNS, that is further facilitated by biofilm formation.  
CONCLUSION 
The study reports relatively high levels of methicillin and multidrug resistance among CoNS 
isolates with a wide range of MAR indices. Considering that CoNS naturally inhabit the skin 
and mucous membranes, they may only be contaminants of clinical specimens. However, they 
are increasingly emerging pathogens, necessitating due diligence when recovered from clinical 
specimens.  
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Table 1 Antimicrobial susceptibility pattern of CoNS and MRCoNS isolates from clinical sources 
Antibiotic  CoNS isolates (n=89) MRCoNS isolates(n=68) 
















Cefoxitin 21 (23.6) NA 68 (76.4) 0 (0.0) NA 68 (100.0) 
Penicillin G 0 (0) NA 89 (100) 0 (0.0) NA 68 (100.0) 
Ceftaroline 68 (76.4) 12 (13.5) 9 (10.1) 50 (73.5) 12 (17.6) 6 (8.8) 
Ciprofloxacin 41 (46.1) 10 (11.2) 38 (42.7) 25 (36.8) 7 (10.3) 36 (52.9) 
Moxifloxacin 46 (51.7) 6 (6.7) 37 (41.6) 30 (44.1) 5 (7.4) 33 (48.5) 
Azithromycin 19 (21.3) 4 (4.5) 66 (74.2) 8 (11.8) 3 (4.4) 57 (83.8) 
Erythromycin 17 (19.1) 6 (6.7) 66 (74.2) 6 (8.8) 5 (7.4) 57 (83.8) 
Gentamicin 85 (95.5) 2 (2.2) 2 (2.2) 64 (94.1) 2 (2.9) 2 (2.9) 
Amikacin 80 (89.9) 5 (5.6) 4 (4.5) 61 (89.7) 3 (4.4) 4 (5.9) 
Chloramphenicol 64 (71.9) 2 (2.2) 23 (25.8) 47 (69.1) 2 (2.9) 19 (27.9) 
Tetracycline 62 (69.7) 4 (4.5) 23 (25.8) 44 (64.7) 3 (4.4) 21 (30.9) 
Doxycycline 65 (73.0) 3 (3.4) 21 (23.6) 46 (67.4) 2 (2.9) 20 (29.4) 
Teicoplanin 73 (82.0) 10 (11.2) 6 (6.7) 59 (86.8) 4 (5.9) 5 (7.4) 
Tigecycline 84 (94.4) NA 5 (5.6) 64 (94.1) NA 4 (5.9) 
Linezolid 85 (95.5) NA 4 (4.5) 65 (95.6) NA 3 (4.4) 
Clindamycin 47 (52.8) 10 (11.2) 32 (35.9) 32 (47.1) 7 (10.3) 29 (42.6) 
Rifampicin 51 (57.3) 0 (0.0) 38 (42.7) 34 (50.0) 0 (0.0) 34 (50.0) 
Sulphamethoxazole/trimethoprim 24 (26.9) 4 (4.5) 61 (68.5) 16 (23.5) 3 (4.4) 49 (72.1) 
Nitrofurantoin 82 (92.1) 2 (2.2) 5 (5.6) 63 (92.6) 2 (2.9) 3 (4.4) 
Vancomycin*  77 (86.5) 13 (13.5) 0 (0.0) 62 (91.2) 6 (8.8) 0 (0.0) 








Table 2 Multiple antibiotic resistance (MAR) index of CoNS isolates 
MAR INDEX Number of isolates 
0.05 5 (5.6%) 
0.10 5 (5.6%) 
0.15 10 (11.2%) 
0.20 5 (5.6%) 
0.25 10 (11.2%) 
0.30 6 (6.7%) 
0.35 8 (8.9%) 
0.40 12 (13.5%) 
0.45 10 (11.2%) 
0.50 8 (8.9%) 
0.55 2 (2.2%) 
0.60 6 (6.7%) 
0.70 1 (1.1%) 












Table 3 Distribution of CoNS isolates depending upon MARI value >0.2 in various departments 
Department  Number of isolates with MAR index >0.2 (n=64) Percentage  
Emergency  5 7.8% 
ICU 11 17.2% 
Medical Ward 10 15.6% 
Obstetrics/gynaecology 1 1.6% 
OPD 7 10.9% 
Surgical Ward 5 7.8% 
Extension Ward 7 10.9% 
















Table 4 Resistance pattern observed in MDR CoNS (n=68) 
Resistance pattern  Number  
FOX-PEN-CIP-MXF-AZM-ERY-GEN-CLI-SXT 1 
FOX-PEN-CIP-MXF-AZM-ERY-CHL-CLI-RIF-SXT 3 




















































Abbreviations: FOX, cefoxitin; PEN, penicillin G; CPT, ceftaroline; CIP, ciprofloxacin; MXF, moxifloxacin; AZM, azithromycin; ERY, erythromycin; GEN, gentamicin; AMK, amikacin; CHL, 
























































































Table S1 Detailed phenotypic and mecA profile of isolates 
Isolate ID CoNS species Ward type MecA Antibiotic resistance profile  











LZD CLI RIF SXT NIT 
C1  S. epidermidis Paediatric OPD NA  R                R  
C3 S. epidermidis Ward & nursery - R R  R R R R R        R  R  
C4 S. epidermidis 
A1 paediatric 
ward - 
R R  R R R R   R      R R R  
C5 
S. hominis ssp 
hominis Paediatric OPD NA 
 R    R R   R      R  R  
C6 S. epidermidis 
Emergency 
department NA 
 R R       R       R  R 
C7 S. haemolyticus 3N ICU + R R  R R R R         R R   
C9 S. epidermidis - + R R  R R R R R    R     R R  
C10 S. haemolyticus ICU + R R  R R R R  R       R R   
C11 
S. hominis ssp 
hominis Casualty NA 
 R                R  
C13 
S. hominis ssp 
hominis Neonatal ICU + 
R R  R R R R   R R R R R R R R R R 
C17 




R R   R R R   R      R    
C18 S. haemolyticus KMMC Clinic NA  R    R R           R  
C19 S. epidermidis Neonatal ICU + R R    R R           R  
C20 




 R R  R     R R R R R R  R R R 
C21 S. sciuri ICU + R R  R R R R         R R R  
C22 S. lentus Ward D + R R  R R R R    R R     R R  
C23 S. lentus Paediatric OPD NA  R                  
C26 S. lentus - + R R                  
C27 S. haemolyticus Ward D + R R       R R R R R R R  R R R 
C31 S. haemolyticus 
A1 Paediatric 
ward + 
R R    R R             
C32 S. sciuri 
E2 Paediatric 
ICU + 
R R  R R R R         R R   
C35 S. saprophyticus 
E1 Paediatric 
ward + 
R R R R R R R   R R R    R  R  
C36 S. saprophyticus Neonatal ICU + R R  R  R R   R R R R R R  R R R 




C38 S. epidermidis 
H2 Medical 
ward + 
R R  R R R R           R  
C39 S. lentus 
5B2 Medical 
ward + 
R R  R R R R   R R R    R R R  
C40 




R R   R R R           R  
C42 S. haemolyticus 
5F Medical 
ward + 
R R  R R R R    R R     R R  
C43 S. lentus 
D1 Medical 
ward + 
R R  R R R R  R R      R  R  
C44 S. gallinarum WARD E + R R                  
C47 




R R    R R           R  
C48 
S. hominis ssp 
hominis 
3F Obstetrics & 
Gynaecology 
ward + 
R R    R R           R  
C49 S. capitis 
3N Extension 
ward + 
R R  R R R R    R     R R   
C53 S. lentus 3N Main - R R    R R         R R R  
C54 S. haemolyticus 
3N Extension 
ward + 
R R  R R R R         R R   
C55 S. lentus 
Ward & 
Nursery NA 
 R    R R             
C56 S. lentus 
E1 Paediatric 
ward + 
R R R  R R R    R R    R R R  
C57 S. epidermidis 
7B2 Extension 
ward - 
R R R R R R R  R R      R R R  
C58 S. epidermidis Surgical OPD + R R  R R R R   R R R    R R R  
C61 S. haemolyticus 
D1 Medical 
ward + 
R R  R R R           R R  
C66 S. lentus Paediatric OPD NA  R R               R  
C68 S. epidermidis 
7F Paediatric 
ward + 
R R    R R   R R R      R  
C72 S. lentus 
2R Surgical 
ICU NA 
 R                  
C73 S. lentus Ward F NA  R                R  
C74 S. epidermidis Paediatric OPD NA  R   R             R  
C75 S. lugdunensis - NA  R                  
C81 




R R  R R R R         R R R  




C93 S. lentus 
H1 Medical 
ward + 
R R  R R R R   R      R R R  
C100 S. haemolyticus 
Emergency 
department + 
R R    R R           R  
C102 S. haemolyticus Paediatric OPD + R R  R R R R    R R    R R R  
C104 S. capitis 
7F Paediatric 
ward NA 
 R  R R R R    R     R R R  
C105 
S. hominis ssp 
hominis Paediatric OPD NA 
R R  R  R R    R R     R R  
C107 S. lugdunensis - NA  R                  
C110 S. xylosus 
H2 Medical 
ward + 
R R         R R  R   R   
C113 S. xylosus Medical OPD + R R    R R          R   
C114 S. sciuri Medical OPD NA  R    R R             
C116 
S. hominis ssp 
hominis Paediatric OPD NA 
 R    R R           R  
C118 
S. hominis ssp 
hominis Ward D + 
R R R   R R    R R      R  
C119 S. xylosus 
2F Paediatric 
ICU + 
R R R   R R    R R      R  
C120 S. gallinarum Paediatric OPD + R R    R R   R        R  
C121 




R R                R  
C122 
S. hominis ssp 
hominis Paediatric OPD + 
R R                R  
C123 S. haemolyticus 
Emergengy And 
Accident Unit NA 
 R    R R             
C125 S. arlettae KMMC Clinic + R R    R R   R      R R R  
C126 S. epidermidis 
1F Male 
surgical Ward NA 
 R                  
C127 S. hominis 
1F Male 
Surgical ward + 
R R    R R           R  
C128 S. hominis 
1F Male 
surgical Ward + 
R R  R R R R         R  R  
C129 S. haemolyticus 
1F Male 
Surgical ward + 
R R  R R R R         R R   
C131 S. sciuri 
Emergency and 
Accident Unit + 
R R  R  R R    R R      R  
C132 S. sciuri 
C2 Surgical 
ward + 
R R R R  R R         R R R  
C133 S. epidermidis Paediatric OPD + R R                R  




C135 S. saprophyticus Paediatric OPD + R R  R R R R   R R R      R  
C136 S. succinus H Ward NA  R    R R           R  
C137 S. epidermidis Ward O + R R  R  R R         R  R  
C138 S. hominis H Ward + R R                R  
C139 S. succinus 
3N Extension 
ward + 
R R    R R   R      R R R  
C141 S. haemolyticus 
3N Extension 
ward + 
R R  R R  R          R   
C142 S. succinus Paediatric OPD + R R                R  
C143 S. warneri 3N ICU + R R    R R      R    R R  
C144 S. epidermidis 
3N Extension 
ward + 
R R  R R R R   R      R R R  
C145 S. epidermidis Casualty + R R    R R      R       
C146 S. haemolyticus Paediatric ward + R R               R R  
C147 S. xylosus 
Ward and 
Nursery + 
R R  R R R R   R      R  R  
C148 S. xylosus D5 Ward + R R    R R             
C149 S. hominis KMMC Clinic + R R    R R           R  
C150 S. succinus Paediatric OPD + R R    R R   R R R      R  
C151 S. haemolyticus 
E1 Paediatric 
Ward + 
R R  R R R R          R   
C152 S. haemolyticus ICU + R R  R R            R   
 
   
 
                   
Abbreviations: FOX, cefoxitin; PEN, penicillin G; CPT, ceftaroline; CIP, ciprofloxacin; MXF, moxifloxacin; AZM, azithromycin; ERY, erythromycin; GEN, gentamicin; AMK, amikacin; 
CHL, chloramphenicol; TET, tetracycline; DOX, doxycycline; TEC, teicoplanin; TGC, tigecycline; LZD, linezolid; CLI, clindamycin; RIF, rifampicin; SXT, sulphamethoxazole/trimethoprim; 
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Background: Staphylococcus epidermidis has become an important nosocomial pathogen. 
Multidrug resistance makes S. epidermidis infections difficult to treat. Although considered 
less virulent than its coagulase-positive counterpart, S. epidermidis is an essential carrier of 
mobile genetic elements and antibiotic resistance genes that can be transferred within and 
between staphylococcal species. 
Methods: Sixteen methicillin-resistant S. epidermidis (MRSE) underwent whole-genome 
sequencing and bioinformatics analyses were carried out to ascertain their resistome, virulome, 
mobilome, clonality and phylogenomic relationships.  
Results: In all, 75% of isolates displayed multidrug resistance and were associated with the 
carriage of multiple resistance genes including mecA, blaZ, tet(K), erm(A), erm(B), erm(C), 
dfrG, aac(6')-aph(2'') and cat(pC221) conferring resistance to β-lactams, tetracyclines, 
macrolide-lincosamide-streptogramin B, aminoglycosides and phenicols, that were located on 
both plasmids and chromosomes. Their virulence profiles were evidenced by the presence of 
genes involved in adherence/biofilm formation (icaA, icaB, icaC, atl, ebh, ebp), immune 
evasion (adsA, capC, manA) and antiphagocytosis (rmlC, cdsA, cpsA). The community-
acquired SCCmec type IV was the most common SCCmec type. The CoNS belonged to seven 
multilocus sequence types (MLSTs) and carried a diversity of mobile genetic elements such as 
phages, insertion sequences and plasmids. The bacterial anti-phage defense systems CRISPR-
Cas immunity phage system and Restriction-Modification System (R-M system) and the 
Arginine Catabolic Mobile Element (ACME) involved in immune evasion and transport of 
virulence genes were also found. The insertion sequence, IS256, linked with virulence, was 
found in 56.3% of isolates. Isolates were organised into two major clades with some similarity 




Conclusion: Whole-genome sequencing and bioinformatics analysis provide insights into the 
likely pathogenicity and antibiotic resistance of S. epidermidis, necessitating surveillance of 
this emerging pathogen. 
Keywords: Staphylococcus epidermidis, antibiotic resistance, whole-genome sequencing, 
genomics. 
Running title: Genomics of Staphylococcus epidermidis in South Africa 
 
 1.0 INTRODUCTION 
Staphylococcus epidermidis are coagulase negative staphylococci (CoNS) that are commensals 
of the skin microbiome. Among the CoNS, S. epidermidis and S. haemolyticus, together 
referred to as the S. epidermidis group, are the most prevalent in clinical settings (Azih and 
Enabulele, 2013) and can behave as pathogens by colonising medical devices, infecting 
surgical wounds, and causing bacteraemia (Cabrera-Contreras et al., 2019). CoNS infection is 
commonly associated with device-associated healthcare infection. S. epidermidis is considered 
clinically relevant, moderately pathogenic and is known to display multidrug and methicillin 
resistance that complicates treatment (Becker et al., 2014, Xu et al., 2015). The mecA gene, 
which mediates methicillin resistance, is highly conserved in S. epidermidis, easily transferred 
to other staphylococcal species by horizontal transmission (Méric et al., 2015) and borne on 
the mobile genetic element (MGE) staphylococcal cassette chromosome, SCCmec, which is 
shared between S. epidermidis and S. aureus (Méric et al., 2015). It is estimated that globally, 
S. epidermidis together with other coagulase-negative staphylococci (CoNS) and S. aureus, 
cause 30% of hospital-associated infections (Xu et al., 2018).  
S. epidermidis is an important carrier of antibiotic resistance genes (ARGs), which can be 




epidermidis is further enhanced by virulence genes associated with adherence/biofilm 
formation, phenol-soluble modulins and various MGEs such as plasmids, insertion sequences 
(ISs), transposons, pathogenicity islands and phages that are involved in the acquisition and 
transmission of resistance and virulence characteristics (Bouchami et al., 2016, Rolo et al., 
2017). The arginine catabolic mobile element (ACME) system, a pathogenicity island thought 
to facilitate host colonisation and immune evasion has generated interest in recent years 
(O’Connor et al., 2018). According to recent phylogenetic studies, the ACME most likely 
originated from S. epidermidis and transmitted to S. aureus through horizontal transfer (Onishi 
et al., 2013, Planet et al., 2013).  
Other factors that have been associated with pathogenicity in S. epidermidis include the 
metabolic state of the bacterial cell, genomic rearrangements in pathogenic isolates facilitated 
by IS256 and the conjugative transfer of antibiotic resistance (Cabrera-Contreras et al., 2019).  
The widespread sequence types ST5, ST12 and ST23 have been reported to be exhibit high 
resistance against most antibiotic drug classes (Martínez-Meléndez et al., 2016). Additionally, 
there is increasing rifampicin resistance in S. epidermidis isolates belonging to ST2 and ST23 
in Europe, the USA and Australia (Lee et al., 2018). This observed resistance conferred by 
mutations in the rpoB gene have independently emerged, supporting the assertion that few, 
well-adapted clonal lineages of S. epidermidis abound in clinical environments (Lee et al., 
2018). 
In this study, we describe the genomic features of methicillin-resistant S. epidermidis (MRSE) 
isolated from hospitals within the KwaZulu-Natal province in South Africa, specifically their 
resistome, virulome, mobilome, clonality and phylogenies together with associations between 





2.0 MATERIALS AND METHODS 
2.1 ETHICAL APPROVAL 
Ethical approval for the study was obtained from the Biomedical Research Ethics Committee 
of the University of KwaZulu-Natal under reference number BREC/00001302/2020. This 
study was a sub-study of the overarching research programme on Antibiotic Resistance and 
One Health (Reference: BCA444/16). 
2.2 DESCRIPTION OF STRAINS AND ANTIMICROBIAL SUSCEPTIBILITY 
TESTING 
Sixteen MRSE isolates were selected as a sub-sample from the initially identified and screened 
89 CoNS isolates and subjected to whole-genome sequencing. S. epidermidis isolates were 
mainly selected because of their clinical relevance, known for their role as the most frequent 
cause of nosocomial infections and their well-documented ability to form biofilms. The sixteen 
clinical MRSE isolates collected from patients in three hospitals in the uMgungundlovu District 
in the KwaZulu-Natal Province, South Africa, had been subjected to initial identification by 
Gram staining, colony characteristics and the Staphaurex™ Latex Agglutination Test (Thermo 
Scientific, Kent, U.K). Speciation of isolates was done using the automated VITEK 2 system 
(BioMérieux, Marcy-L’Etoile, France). 
The antibiotypes for 20 antibiotics were determined by the Kirby-Bauer disk-diffusion method, 
or by the broth microdilution method. The Clinical and Laboratory Standard Institute (CLSI) 
guidelines were used to interpret their antimicrobial susceptibility (Clinical and Laboratory 
Standards Institute, 2016). Antibiotics tested (disc diffusion) included penicillin G (10 µg), 
cefoxitin (30 µg), ceftaroline (30 µg), ciprofloxacin (5 µg), moxifloxacin (5 µg), azithromycin 
(15 µg), erythromycin (15 µg), gentamicin (120 µg), amikacin (30 µg), chloramphenicol (30 




linezolid (30 µg), clindamycin (10 µg), rifampicin (5 µg), sulphamethoxazole/trimethoprim 
(1.25/23.75 µg) and nitrofurantoin (300 µg). The minimum inhibitory concentration (MIC) of 
vancomycin was determined by the broth microdilution method according to CLSI guidelines 
(Clinical and Laboratory Standards Institute, 2016). The cefoxitin disc diffusion was used to 
detect methicillin resistance and molecularly confirmed by PCR detection of the mecA gene.  
2.3 PHENOTYPIC DETECTION OF BIOFILM FORMATION 
Biofilm forming abilities of isolates were assessed by the tissue culture plate method described 
by Mitchell et al. (2010) (Mitchell et al., 2010). Briefly, isolates were grown in trypticase soy 
broth (TSB) supplemented with glucose for 24h at 37°C. Sterile 96-well microtiter plates were 
inoculated with bacterial suspension adjusted to 0.5 MacFarland standard and incubated at 
37°C for 24h. The plates were washed after incubation and dried at room temperature. The 
wells then stained with 0.1% crystal violet solution, incubated at room temperature for 10 
minutes and washed thrice with distilled water. A 30% acetic acid solution was added to 
solubilize the crystal violet retained by the biofilm. The optical densities of samples in each 
well were read at 570 nm using a microtiter plate reader (BMG LABTECH, Offenburg, 
Germany). Staphylococcus epidermidis ATCC 35984 was used as positive control. Isolates 
were categorised as strong, moderate, weak and non-biofilm formers.  
2.4 WHOLE-GENOME SEQUENCING  
Genomic DNA (gDNA) from pure colonies of MRSE isolates grown from overnight cultures 
was extracted and purified using the GenElute Bacterial Genomic DNA kit (Sigma Aldrich, St. 
Louis, USA), according to the manufacturer’s instructions. DNA was checked by agarose gel 
electrophoresis, while the concentration and purity were determined using Nanodrop™ 1000 
spectrophotometer (Thermo Scientific, Wilmington, Delaware, USA). For library preparation, 




generate paired-end libraries, followed by whole-genome sequencing on the Illumina MiSeq 
platform (Illumina, San Diego, CA, USA) at the Sequencing Core Facility, National Institute 
for Communicable Disease, Johannesburg, South Africa.  
Quality trimming of the sequence reads was done by the use of Sickle version 1.33 
(https://github.com/najoshi/sickle), while assembler, SPAdes version 3.11 (Bankevich et al., 
2012) and the CLC Genomics Workbench version 10.1 (CLC, Bio-QIAGEN, Aarhus, 
Denmark) were used for de novo assembly of the reads. The assembled contiguous sequences 
were submitted via the NCBI Prokaryotic Genome Annotation Pipeline to GenBank for gene 
annotation. The generated contigs were analysed further to investigate genetic elements of 
interest.  
2.5 BIOINFORMATIC ANALYSES 
2.5.1 PATHOGENICITY, RESISTOME AND VIRULOME ANALYSIS 
The prediction of isolates’ pathogenicity towards human hosts was determined by 
PathogenFinder available at https://cge.cbs.dtu.dk/services/PathogenFinder/. The assembled 
genomes from the WGS data were annotated to predict and identify the resistome using 
ResFinder 4.1 (with a minimum length and threshold of 60% and 90%, respectively), and the 
Comprehensive Antibiotic Resistance Database (CARD) 
(https://card.mcmaster.ca/analyze/rgi) (Alcock et al., 2020), using the default selection criteria 
‘perfect and strict hits only’. The platforms were used side by side to compensate for the 
inherent deficits in individual platforms.  
We determined the genetic basis (chromosomal single nucleotide polymorphism [SNP]) for 
observed fluoroquinolone and rifampicin resistance from the assembled genomes by 
investigating mutations conferring resistance to fluoroquinolones and rifampicin using 




epidermidis (Staphylococcus epidermidis strain ATCC 12228) were aligned with the 
corresponding genes from resistant isolates in this study with BLASTn to call for SNPs in those 
genes using the Clustal Omega tool (European Molecular Biology Laboratory). Thus, the 
mutations in the genomes of the study isolates were manually curated.  
VirulenceFinder 2.0 (using a minimum length of 60% and a threshold of 90%) 
(https://cge.cbs.dtu.dk/services/VirulenceFinder/) (Joensen et al., 2014), virulence factor 
database (VFDB) (http://www.mgc.ac.cn/cgi-bin/VFs/v5/main.cgi?func=VFanalyzer) and  
BacWGSTdb (http://bacdb.cn/BacWGSTdb) were used to screen for the presence of virulence 
genes. Various virulence determinants consistent with different major virulence factors 
(including adherence, enzymes, immune evasion, secretion system, toxins, anti-phagocytosis, 
biofilm formation/adherence and intracellular survival) associated with S. epidermidis were 
investigated.  
2.5.2 IN SILICO MULTILOCUS SEQUENCE TYPING (MLST) 
MLST was performed in silico using MLST 2.0 program software 
(https://cge.cbs.dtu.dk/services/MLST/) available on the website of the Center for Genomic 
Epidemiology (Larsen et al., 2012) and the pubic molecular typing database, PubMLST 
(https://pubmlst.org/). Sequence types were assigned by matching the internal fragments of the 
seven housekeeping genes (arcC, aroE, gtr, mutS, pyrR, tpiA and yqiL) from S. epidermidis to 
identify alleles (Thomas et al., 2007). We performed eBURST analyses (Feil et al., 2004) in 
the MLST database to identify clones similar to obtained STs. 
2.5.3 IDENTIFICATION OF MOBILE GENETIC ELEMENTS (MGES) AND 
GENETIC SUPPORT ENVIRONMENT 
MGEs associated with antibiotic resistance genes and their genetic context were investigated 




et al., 2008) was used to ascertain MGEs and the genetic support environment. The web-based 
typing tool SCCmecFinder (https://cge.cbs.dtu.dk/services/SCCmecFinder/) was used for the 
in silico determination of the SCCmec types and their structural position in the MRSE isolates. 
In silico detection of plasmid replicon types was done out using PlasmidFinder 2.1, available 
at https://cge.cbs.dtu.dk/services/PlasmidFinder/ (Carattoli et al., 2014). 
The PHAge Search Tool Enhanced Release (PHASTER) (available at https://phaster.ca/) was 
used to identify and annotate prophage sequences within the genomes (Arndt et al., 2016). Only 
the prophage regions identified as ‘intact’ by PHASTER were considered. The region positions 
of the prophages were BLASTED on CARD to determine if the prophages harboured resistance 
genes. Insertion sequences (ISs) and transposons flanking the resistance genes were identified 
using the MobileElementFinder v1.0.3 (2020-10-09) 
(https://cge.cbs.dtu.dk/services/MobileElementFinder/) (Johansson et al., 2020), available on 
the website of the Center for genomic epidemiology (https://cge.cbs.dtu.dk/services/). We used 
NCBI annotations to determine the support environment of the resistance genes.  
2.5.4 CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC 
REPEATS/CRISPR-ASSOCIATED (CRISPR/CAS SYSTEM), ARGININE 
CATABOLIC MOBILE ELEMENT (ACME) AND RESTRICTION-MODIFICATION 
SYSTEM (RMS) 
We searched for CRISPR and cas genes in the sequence data using the CRISPRCasFinder, 
available at https://crisprcas.i2bc.paris-saclay.fr/CrisprCasFinder/Index, using the default 
advanced settings for CRISPR and the clustering model ‘SubTyping’ for cas. Restriction-
ModificationFinder 1.1, available at https://cge.cbs.dtu.dk/services/Restriction-
ModificationFinder/, was used to investigate the presence of the R-M system, using a minimum 
length of 60% and a threshold for %ID of 95% (Roer et al., 2016). The ACME genes within 




arc operon, the opp3 operon, and the kdp operon, was used to classify the ACME components 
as follows: arc and opp3 operons (type I), the arc operon only (type II), the opp3 operon only 
(type III), the arc and kdp operons (type IV), and all three arc, opp and kdp operons (type V), 
using Pathosystems Resource Integration Center (PATRIC) (https://www.patricbrc.org/) 
annotations.  
2.5.6 PHYLOGENETIC ANALYSES USING WGS SNPs AND WGS MLST TREES 
Phylogenetic trees were constructed based on the maximum likelihood method using the 
CSIPhylogeny ( https://cge.cbs.dtu.dk/services/CSIPhylogeny/) (Kaas et al., 2014) which 
performs SNP calling, filtering of the SNPs, and inferring phylogeny based on the concatenated 
alignment of the high-quality SNPs, using the assembled contigs. The analysis was performed 
on the platform using default parameters as follows: minimum depth at SNP positions, 10X; 
minimum relative depth at SNP positions of 10%; minimum distance between SNPs (prune) at 
10bp; minimum SNP quality, 30; minimum read mapping quality of 25 and minimum Z-score 
of 1.96. Staphylococcus aureus ATCC 25923 was used as the reference strain. Assembled 
genomes for comparison were uploaded. To see how our isolates compare to S. epidermidis 
genomes from Africa, we searched and downloaded S. epidermidis genomes reported in Africa 
and curated on the PATRIC website and included them in the analysis. To edit and visualize 
the phylogenetic tree, we used the Figtree programme 
(http://tree.bio.ed.ac.uk/software/figtree/). We used Phandango (Hadfield et al., 2018) to 
visualize the phylogeny in association with the isolate demographics, resistance mechanisms, 
in silico WGS typing metadata.    
2.6 NUCLEOTIDE SEQUENCE ACCESSION NUMBERS 
The nucleotide sequences of the 16 MRSE strains (C35, C36, C38, C40, C68, C81, C119, 




in GenBank database in the Bioproject number PRJNA667485, with the following accession 
numbers:  JADPYQ000000000, JADPYL000000000, JADPYK000000000, 
JADPYJ000000000, JADPYN000000000, JADPYP000000000, JADBPJ000000000, 
JADPYR000000000, JADPYO000000000, JADBPI000000000, JADPYI000000000, 
JADWON000000000, JADBPA000000000, JADBPG000000000, JADWOP000000000, 
JADBPQ000000000.  
 
3.0 RESULTS  
3.1 PHENOTYPIC CHARACTERISTICS OF MRSE ISOLATES  
Sixteen blood culture MRSE isolates were used in the WGS analysis. All isolates were 
confirmed as methicillin-resistant by PCR detection of the mecA gene. Twelve (75%) were 
multidrug-resistant, defined as resistance to at least one antibiotic in three or more distinct 
antibiotic classes (Magiorakos et al., 2012). Two isolates were resistant to the anti-MRSA 
cephalosporin ceftaroline, while one and two isolates were resistant to tigecycline and 
teicoplanin, respectively. None of the isolates were resistant to vancomycin; however, one 
isolate showed intermediate susceptibility to vancomycin, while one isolate each was resistant 
to linezolid and nitrofurantoin. Antibiotic susceptibility profiles of MRSE isolates used in this 
study are shown in Table 1. 
3.2 GENOME AND ASSEMBLY CHARACTERISTICS 
The genome and assembly characteristics of the sequences, including size, number of contigs, 
number of RNAs, GC content (%), number of coding sequences, N50 and L50 are shown in 
supplementary Table S1. The isolates' draft genome size ranged from 1.9 Mb to 2.9 Mb, with 




3.3 GENOMIC CHARACTERISATION OF RESISTOME  
The identities of isolates and observed phenotypic resistance were confirmed by the genomic 
data using the Pathogenwatch platform. Antibiotic resistance genes conferring resistance to β-
lactams (mecA, blaZ), tetracyclines [tet(K), tet(M)], macrolide-lincosamide-streptogramin B 
antibiotic (MLSB) [erm(A), erm(B), erm(C), msr(A), and mph(C)], trimethoprim-
sulfamethoxazole (dfrG), aminoglycosides [aac(6')-aph(2''), aph(3')-III, aadD], 
chloramphenicol [cat(pC221), cat(pC233)], fosfomycin [fosB], were detected in isolates (Table 
2). All MRSE isolates possessed either the mecA or blaZ genes. Resistance determinants for 
tigecycline, teicoplanin, linezolid and nitrofurantoin were not detected. The mechanism(s) 
behind these resistance phenotypes are currently under investigation (He et al., 2019, 
Wardenburg et al., 2019, Yushchuk et al., 2020). There was discordance between resistance 
phenotype and ARGs, relating to trimethoprim-sulfamethoxazole, tetracycline, doxycycline, 
rifampicin and erythromycin resistance phenotypes. Even though some isolates were 
phenotypically resistant to these antibiotics, no corresponding ARGs were detected.   
Thirteen out of the 16 isolates showed an agreement between the cefoxitin resistance phenotype 
and the mecA gene. The tetracycline resistance genes tet(K) and tet(M) were found in 4/5 (80%) 
of isolates phenotypically resistant to tetracycline. The aminoglycoside resistance mechanisms 
aac(6')-aph(2''), aad and aph(3')-III were found in 6/16 (37.5%) of isolates; however none of 
those isolates were phenotypically resistant to gentamicin or amikacin. Furthermore, the MLSB 
resistance mechanisms msr(A), mph(C), erm(A), erm(B) and erm(C) were also detected in 
11/12 (91.6%) of phenotypically resistant isolates. The dfrG gene was found in 9/14 (62.3%) 
of isolates resistant to sulfamethoxazole/trimethoprim. We identified known and putatively 
novel mutations in the gryA, parC and parE quinolone resistance-determining region (QRDR) 
genes in some fluoroquinolone-resistant isolates. (Table 3). We detected no mutation in the 




case, may be mediated by a mechanism yet to be described. We identified the major facilitator 
superfamily (MFS) antibiotic efflux pump (norA), which can also confer resistance to 
fluoroquinolones.  
Seven mutations were found in gyrA, 4 mutations in parC but no mutations were detected in 
gyrB. We further found 2 mutations (S486Y and Y737S) in the rpoB gene.  
3.4 PATHOGENICITY AND VIRULOME 
The mean probability of isolates being pathogenic to humans ranged from 0.727-0.968 and 
matched several pathogenic families. The virulome analysis revealed putative virulence genes 
encoding proteins belonging to multiple virulence categories of S. epidermidis, i.e., 
adherence/biofilm formation, enzymes, immune evasion, secretion, toxin, anti-phagocytosis, 
intracellular survival and stress adaptation (Table 4). 
3.5 WGS-BASED MULTILOCUS SEQUENCE TYPING (MLST) 
In silico MLST analyses identified seven different MLST types, namely sequence types (ST) 
ST54 (2), ST83 (1), ST2 (2), ST490 (1), ST640 (1), ST210 (1) and ST59 (2). The most resistant 
isolate belonged to ST54 and harboured nine ARGs encoding resistance to five antibiotic drug 
classes (Table 2). The observed STs were from three different hospitals with sequence type 
ST59 (n=2) from the same hospital but different wards. The eBURST analyses matched the 
various STs to the closest global ancestry STs. ST54 matched STs originating from human and 
animal sources from Denmark, Italy, Japan, India and Russia. The eBURST analyses also 
matched ST2 to the highest number of similar clones originating from several countries 






3.6 MOBILOME AND THE GENETIC SUPPORT ENVIRONMENT 
In silico SCCmec typing/subtyping revealed six SCCmec types/subtypes: SCCmec type 
IV(2B), SCCmec type IVg(2B), SCCmec type V(5C2), SCCmec type IVa(2B), SCCmec type 
XIII(9A) and SCCmec type I(1B). Isolates with SCCmec type I(1B) (n=2) belonged to 
sequence type (ST59), while SCCmec type V(5C2) isolates (n=2) belonged to sequence type 
ST54. The community-acquired SCCmec type IV (in various subtypes) was the most common 
type found. The mecA gene (but not mecC) was detected by SCCmecFinder as the sole 
mechanism of resistance in MRSE isolates. All β-lactam resistant isolates possessed the blaZ 
gene (encoding β-lactamase) and their regulator genes blaR and blaI. 
Plasmid analysis by PlasmidFinder and BacWGSTdb (http://bacdb.org/BacWGSTdb/) 
revealed 24 different plasmid replicon types. Rep10 (10), rep7a (7) and repUS43 (6) were the 
most predominant plasmid replicon types. Replicon types rep39, repUS9 and rep19b were 
found in 4 (25%), 4 (25%) and 5 (31.2%) of isolates, respectively.  
We found ISs in all 16 isolates. In total, 10 different IS types belonging to 6 different IS families 
were detected (Fig S1). The most predominant IS families were IS256, 1S200/IS605 and IS3. 
IS256, closely linked to biofilm formation and virulence in pathogenic MRSE isolates, was 
found in 9 isolates, 7 of which had the ica operon. The resistance gene aac(6')-aph(2'') was 
found in association with IS256, while the virulence gene gelE (predicted to be linked with 
Enterococcus) was found in association with ISEfa11 in one isolate (C81). Furthermore, the 
resistance gene erm(A) was also found in association with the transposon Tn554 in some 
isolates. Using NCBI annotation, we found the blaZ gene surrounded by regulator genes blaR 
and blaI. Similarly, the mecA gene was frequently found with the regulatory gene mecI (a 
repressor) and mecR1 (a sensor inducer) and ISs (IS257 and IS1182). Table 5 and Figure 1 
describe the genetic support environment of some resistance genes found in this study, with 




The PHASTER tool identified intact prophages integrated into the genomes of 10 isolates.  
PHAGE_Staphy_StB20 (n=9), and PHAGE_Staphy_187 (n=5) were the most predominant 
prophages. Prophages did not harbour resistance genes. Prophage characteristics, including GC 
content and number of coding sequences, are shown in Supplementary Table S3.  
3.7 IDENTIFICATION AND CLASSIFICATION OF CRISPR-CAS ELEMENTS, 
ARGININE CATABOLIC MOBILE ELEMENT (ACME) AND RESTRICTION-
MODIFICATION SYSTEM (R-M SYSTEM) 
The CRISPRCasFinder identified sequences with clustered regularly interspaced short 
palindromic repeats (CRISPR). All isolates possessed at least one sequence with CRISPR. 
However, CRISPR-associated (cas) genes were not detected. Two isolates possessed the R-M 
system, and both were classified as type II. ACME was identified in 5 isolates and were 
classified as type I (3) and type III (2).  
3.8 PHYLOGENETIC RELATIONSHIP AMONG S. EPIDERMIDIS ISOLATES IN 
THIS STUDY AND WITH OTHER AFRICAN S. EPIDERMIDIS ISOLATES 
The phylogenetic relationship between the 16 study isolates and 5 collected isolates from 
African countries, together with a reference strain, was determined (Fig 2a and 2b). The tree 
consists of two main clades, A and B, defined by the branches. Clade B was further organised 
into sub-clades B1 and B2, further organized into B2a and B2b, and subsequently into B2bi 
and B2bii. Generally, isolates did not cluster according to STs, except C36 and C40 (both 
ST54).  
4.0 DISCUSSION 
In this study, we sequenced MRSE isolates from clinical sources from hospitals in the 




studied the genomic characteristics, including resistance and virulence determinants, MGEs 
and the genetic environments of the resistance genes observed.  
Concerning pathogenicity, there is no apparent genetic difference between commensal non-
pathogenic and pathogenic S. epidermidis strains, albeit nosocomial S. epidermidis strains are 
boosted with resistance and virulence genes (Méric et al., 2015). The 16 genomes herein 
analysed were mostly from paediatric/neonatal patients.  S. epidermidis is commonly recovered 
from bacterial bloodstream infections from neonatal units as a probable causative agent (Asante 
et al., 2020). Children are particularly susceptible to acquiring S. epidermidis in perinatal 
hospitals (Cabrera-Contreras et al., 2019). 
We detected various resistance genes encoding resistance to several antibiotic drug classes that 
explained the observed phenotypic resistance in isolates. Resistance genes found in this study 
encode enzyme inactivation (β-lactamases), enzyme modification of antibiotic target such as 
erm genes that mediate macrolide-lincosamide-streptogramin B (MLSB) resistance, the 
aminoglycoside-modifying enzymes, replacement of antibiotic target site as in mecA-mediated 
resistance to β-lactams in staphylococci, and major facilitator superfamily (MFS) antibiotic 
efflux pump (norA), which can also confer resistance to fluoroquinolones (Foster, 2017). There 
was no association between ARG type and hospital/department. However, mecA, blaZ and 
norA genes were found in nearly all isolates from all three hospitals. As well, erm(C), msr(A), 
dfrG and mph(C) genes were distributed across the regional hospital but were not ward specific, 
while dfrG, tet(K), and erm(B) were frequently found in the district hospital.  
Generally, there was considerable agreement between resistance phenotypes and genotypes 
observed with ARGs affirming the phenotype, except in a few instances. The detection of the 
β-lactamase gene, blaZ and the regulator genes blaR and blaI are most likely responsible for 




mecA genotype could be due to alternative mechanisms of resistance, hetero-resistance or 
drawback of the present phenotypic testing methods (Band et al., 2019, Harrison et al., 2019). 
The lack of phenotypic resistance to gentamicin and amikacin even though aminoglycoside 
resistance genes were detected could be due the lack of expression of these genes. This could 
also be due to the fact that amikacin is not affected by most aminoglycoside-modifying 
enzymes (Doyle et al., 2020). Other factors that can cause discordance between phenotype and 
genotype include sequence quality of the sample and the read depth of the sequencing platform; 
insufficient read depth leads to lower coverage (Doyle et al., 2020). The molecular mechanism 
of resistance in the tigecycline-resistant isolate in this study is unknown and there was no tet(X) 
gene detected. Similarly, even though resistance phenotypes were observed for teicoplanin, 
linezolid and nitrofurantoin, molecular resistance mechanisms were not detected in their 
genomes. Limitations of current phenotypic detection methods could be responsible for such 
discrepancies (Cabrera-Contreras et al., 2019). Novel resistance mechanisms may explain these 
observed phenotypes and is subject to further studies (Osei Sekyere and Asante, 2018).  
We found mutations in the gyrA, gyrB, parC, parE and the rpoB genes. In the gyrA gene, the 
substitution S84Y, a mutation known to confer fluoroquinolone resistance (Yamada et al., 
2008), was detected, while putatively novel mutations V304I, E888D, D890E, S891D, D892S, 
E893D were also detected. The effects of the individual mutations on fluoroquinolone 
resistance were not investigated in this study.  
Several virulence genes are shared by both pathogenic and commensal S. epidermidis strains 
(Otto, 2009). Consistent with hospital and commensal S. epidermidis strains isolated 
worldwide (Cabrera-Contreras et al., 2019), our isolates were characterised by 
adherence/biofilm forming genes and multidrug resistance. Twelve out of the 16 isolates were 
biofilm formers as determined by the phenotypic tissue culture plate method, most of which 




used as measures of pathogenicity in S. epidermidis (Murugesan et al., 2018) were not detected 
in 9 and 7 isolates, respectively. The isolates, however, cannot be dismissed as non-pathogenic, 
as they can deploy several other virulence factors such as immune evasion (encoded by hasC, 
rfbA-1, adsA, capC), toxins (encoded by hlb, hlyA, cysC1) anti-phagocytosis (rmlC, cdsA, 
cpsA, cpsF), stress adaptation (katA, katA, mntB, sodCI) and intracellular survival (lplA1).  
S. epidermidis form biofilms on medical devices and on biotic surfaces that can lead to the 
breakaway of single cells, spreading and colonising other parts of the body, leading to 
infections such as endocarditis and sepsis. Biofilm formation allows S. epidermidis to persist 
at the infection site and beyond and form a physical barrier to antibiotics. Thus, strains with 
biofilm-forming ability are considered more virulent (Becker et al., 2014). The ica operon, 
which facilitates the adherence of staphylococci to components of the host extracellular matrix, 
plays a part in the formation of biofilm (Ghasemian et al., 2015). Furthermore, S. epidermidis 
possesses other determinants known to facilitate attachment to surfaces and promote various 
biofilm formation stages. These genes include the elastin binding protein gene ebp, serine 
protease genes sspA, autolysin gene atlE, lipase genes geh, the cell wall-associated fibronectin-
binding protein gene ebh and the nuclease gene, nuc (Xu et al., 2018).  
These antibiotic resistance and virulence genes have been shown to form part of the accessory 
genome organised within and between species. Prediction of isolates’ pathogenicity towards 
human hosts yielded a high average probability score (Pscore ≈ 0.937). This pathogenicity score 
juxtaposed with the several virulence genes possessed by isolates, support their pathogenic 
potential to humans (Adzitey et al., 2020). 
Methicillin-resistant staphylococci have been associated with MGEs, such as the SCCmec and 
ACME. MGEs may be repositories of resistance and virulence genes (Foster, 2017, Sheppard 
et al., 2016). Their importance is related to their mobile nature, which allows them to transfer 




resulting in frequent exchange of genetic material within the population. The variability 
observed in the genome of S. epidermidis points to the active gene exchange. We thus looked 
for prophages, CRISPR-Cas system, transposons and insertion sequences to investigate this 
phenomenon. The study isolates possessed various ISs, that belong to different families. IS256 
has been found to be present in pathogenic S. epidermidis strains and closely linked with 
virulence and biofilm formation among MRSE (Murugesan et al., 2018). This observation was 
affirmed by the fact that all but 2 of our isolates with IS256 also contained the ica operon 
involved in biofilm formation. Indeed, only one isolate (C133) harboured the ica gene that did 
not have IS256. IS256 has been shown to facilitate genomic rearrangements in pathogenic S. 
epidermidis isolates (Cabrera-Contreras et al., 2019).  
In this study, the plasmids rep10, repUS43, rep7a, rep7b, repUS70 frequently carried the 
resistance genes erm(C), tet(M), tet(K), catpC233, and blaZ, respectively, whereas other genes 
were chromosomally-mediated. These plasmid-borne genes can easily be transferred by 
conjugation between cells, spreading resistance (Cabrera-Contreras et al., 2019). Furthermore, 
although prophages can transfer DNA between cells by transduction, no resistance genes were 
carried by prophages detected in this study. Transposons detected in the genome of 2 isolates, 
like plasmids, may carry genes beneficial to bacteria, such as those involved in antibiotic 
resistance (Mbelle et al., 2019). They can transpose from the chromosome and can move to 
different sites of the DNA within a cell. In this study, the transposon Tn554 was found to flank 
the resistance gene erm(A) in some isolates, which may allow it to jump between the 
chromosome and the plasmid.  The small sample size of isolates in this study limits associations 
between ARGs, virulence genes, MGEs and isolate demographics. However, the carriage of 
ARGs on diverse MGEs enhances the mobilization and dissemination of these genes. 
CRISPR-Cas system is a defense mechanism deployed by bacteria against phage infection. 




memory of the infection. Bacteria may use this to neutralise future infections caused by similar 
viruses by cleaving the viral genetic sequence before they can take control of the bacterial host 
(Makarova et al., 2020). All isolates bore at least one sequence with CRIPSR (Table 2), ten of 
which contained at least one intact prophage. The two isolates found with the R-M system were 
classified as type II. Like the CRISPR-Cas system, the R-M system is a defense system 
developed by bacteria against invasion by bacteriophages (Vasu and Nagaraja, 2013).  
The ACME system, a pathogenicity island, has generated interest and is thought to facilitate 
the host colonisation and immune evasion and transports virulence or survival genes 
(O’Connor et al., 2018). ACME elements were detected in 31.3% of study isolates. This is 
lower than the prevalence of 40 to 65.4% reported in MRSE in a study that investigated the 
diversity of the ACME in S. epidermidis from the oral cavity and periodontal pockets 
(O’Connor et al., 2018). In comparison, an ACME carriage of 16% was detected in a study that 
compared the resistance and virulence profile of S. epidermidis isolates from bloodstream 
infections and nares of neonates (Salgueiro et al., 2017). ACME shows a higher prevalence and 
greater diversity in S. epidermidis compared with S. aureus. In S. aureus, studies have proved 
that ACME is usually incorporated in bacterial chromosome adjoining the SCCmecIV element 
(Diep et al., 2006, Ellington et al., 2008). In this study however, no association between ACME 
and SCCmec type IV was found, which is consistent with results obtained by Du et al. (2013). 
Most of the resistance genes were bracketed by either transposases or ISs or a combination of 
both and these can transfer resistance genes within and between plasmids and chromosomes 
(Mbelle et al., 2019) potentially within and between bacterial species.  
The cat(pC233) gene was bracketed by plasmid mobilization relaxosome protein MobC in 
isolate C36, while the erm(C) gene was bracketed by the 23S rRNA methylase leader peptide 




gene was surrounded by the type I toxin-antitoxin system, which may play a role in biofilm 
and persister cell formation (Wang and Wood, 2011). (Table 5 and Fig 1).  
MLST has shown the population structure of S. epidermidis to be clonal (Thomas et al., 2007). 
The clonal lineages ST2, ST5, and ST23, which are the most commonly reported in hospital 
environments as well as other sequence types of S. epidermidis are globally distributed 
(Miragaia, 2018). ST2 in particular, is predominant in the hospital environment. In this study, 
2/16 isolates belonged to ST2. Both ST2 isolates in this study possessed the icaA gene and 
IS256, both of which are linked to enhanced pathogenicity (Du et al., 2013). Also, ST35, ST81 
and ST89 were not represented in this study, consistent with global data (Cabrera-Contreras et 
al., 2019). Despite the relatedness of isolates, there is still considerable variation within 
individual isolates pointing to their mobilization on diverse MGEs.  
5.0 Conclusion  
 S. epidermidis isolates from public hospitals in uMgungundlovu exhibited several 
permutations and combinations of ARGs, virulence genes and MGEs pointing to a complex 
milieu of mobilized antibiotic resistance and pathogenic characteristics in clonal and 
multiclonal strains.  
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Table 1 Antibiotic susceptibility characteristics of the MRSE collected from blood cultures 
Isolate 
ID 
Sex  Antibiotic resistance profile 
  FOX PEN CPT CIP MXF AZM  ERY GEN AMK CHL  TET DOX TGC TEC LZD CLI RIF SXT NIT VAN 
C35 F R R R R R R R S S R R R S S S R S R S S 
C36 M R R S R I R R S I R R R R R R I R R R S 
C38 F R R S R R R R S S S S S S S S S S R S S 
C40 M R R S S R R R S S S S S S S S S S R S S 
C68 M R R S I S R R S S R R R S S S S S R S S 
C81 F R R S R R R R S S S S S S S S R R R S S 
C119 M R R R S S R R S S S R R S I S S S R S I 
C122 M R R S S S S S S S S S S S S S S S R S S 
C127 M R R S S S R R S S S S S S S S S S R S S 
C133 M R R S S S S S S S S S S S S S S S R S S 
C135 M R R S R R R R S S R R R S S S S S R S S 
C137 U R R S R I R R I S S S S S S S R S R S S 
C138 F R R S S S S S S S S S S S S S S S R S S 
C145 M R R S S S R R S S S S S S R S S S I S S 
C146 M R R S S S S S S S S S S S S S S R R S S 
C148 F R R S S S R R S S S S S S S S S S S S S 
Abbreviations FOX, cefoxitin; PEN, penicillin; CPT, ceftaroline; CIP, ciprofloxacin; MXF, moxifloxacin; AZM, azithromycin; ERY, erythromycin; GEN, gentamicin; 
AMK, amikacin; CHL, chloramphenicol; TET, tetracycline; DOX, doxycycline; TGC, tigecycline; TEC, teicoplanin; LZD, linezolid; CLI, clindamycin; RIF, rifampicin; 
SXT, sulphamethoxazole/trimethoprim; NIT, nitrofurantoin; VAN, vancomycin; R; resistant; I, intermediate; S, susceptible; M, male; F, female; U, unknown.  












Plasmid replicon type R-M 
system 
SCCmec type ACME 
type 








mecA, blaZ, norA, dfrG, tet(K), 
cat(pC221), erm(C), 
rep15, rep19b, rep19c, rep24c, rep39, 
rep21, repUS22, rep7a, repUS43, 
rep10 
- SCCmec type IV(2B) - unknown IS256, ISSau4, ISSep3 10(0) 0.944(482) 
C36 
MecA, blaZ, tet(M), aac(6')-
aph(2''),  aadD, 
cat(pC221),cat(pC233), 
erm(A),erm(C), norA 
rep19b, repUS9, rep10, rep22, rep7a, 
rep7b, repUS43 
Type II SCCmec type V(5C2) - ST54 IS256 5(0) 0.942(540) 
C38 MecA, blaZ, norA, erm(C) rep10, repUS43 Type II SCCmec type IV(2B) - ST83 ISSep3, ISSau4, IS256 3(0) 0.943(555) 
C40 
MecA, blaZ, aac(6')-aph(2''), 
erm(A),erm(C) 
rep10, repUS9, repUS43 - - - ST54 IS256 4(0) 0.944(521) 
C68 
MecA, blaZ, tet(M),tet(K), 
cat(pC221), erm(C),lsa(A),erm(B), 
dfrG 
rep2, repUS11, rep10, rep7a, 
repUS43, repUS12 
- SCCmec type XIII(9A) III ST210 ISSau4, ISEfa11 6(0) 0.947(501) 
C81 
MecA, blaZ, norA, aac(6')-aph(2''), 
cat(pC221), erm(A),erm(C),erm(B) 
rep7a, repUS43, rep2, repUS11, 
rep22, repUS46, repUS23, repUS9, 
rep10 




mecA, blaZ, erm(C), aac(6')-
aph(2''), aac(6')-Ic, dfrG 
rep10, rep19b, rep19c, rep20, rep39, 
repUS70 
- - III unknown IS16, ISSep2, IS256 6(0) 0.947(171) 
C122 
mecA, blaZ, aadD, aac(6')-aph(2''), 
mph(C), msr(A), dfrG 
rep19b, rep19c, rep20, rep39, rep10, - SCCmec type I(1B) I ST59 ISSep3, ISSau4 3(0) 0.951(513) 
C127 
mecA, blaZ, mph(C), msr(A), 
erm(C), dfrG 
rep10, rep19b, rep19c, rep20, rep39 - SCCmec type I(1B) I ST59 ISSau4, ISSep3 4(0) 0.949(548) 
C133 blaZ None  - - - ST490 ISSep3 4(0) 0.964(152) 
C135 
mecA, blaZ, norA, tet(K), msr(A), 
mph(C), cat(pC221), dfrG 





mecA, norA, blaZ, aac(6')-aph(2''), 
erm(A),erm(C), dfrG 
rep10, repUS9, repUS43 - - - unknown IS256 1(0) 0.727(36) 
C138 blaZ, dfrG - - - - unknown ISSep3, ISSau4 7(0) 0.955(328) 
C145 
MecA, blaZ, tet(K), aac(6')-aph(2''), 
aph(3')-III, erm(B) 
rep11a, rep18b, rep2, rep7a - SCCmec type IVa(2B) - ST2 ISSep3, ISSau4, 




MecA, blaZ, msr(A) repUS48 - SCCmec type IVa(2B) - ST640 IS30, ISEc36, ISSep2, 
ISSau4 
4(0) 0.948(121) 
C148 blaZ, tet(K) rep21, rep19c, repUS9, rep5d, rep7a - - - unknown IS256 2(0) 0.948(30) 
RM-System: Restriction-Modification System; ACME-arginine catabolic mobile element: ACME type I (arc and opp3 operons), II (the arc operon only), III 
(the opp3 operon only), IV (arc and kdp operons) and V (arc, opp and kdp operons). Pathogenicity score: Prediction of a bacteria's pathogenicity towards 












Table 3 Mutations in the gyrA, gyrB, parC and parE in the S. epidermidis isolates 
Isolate ID gyrA  gyrB parC parE rpoB 
C35 - - -  N/A 
C135 - - *K272R NONE N/A 
C137 *V304I - *K272R NONE N/A 
C40 - - *K272R NONE N/A 
C38 S84Y, *E888D, *D890E, 
*S891D, *D892S, *E893D 
- *S80F, *D84Y, 
*E231K, *K272R 
NONE N/A 
C36µ - - *K272R NONE - 
C81µ - - *K272R D434V S486Y 
C146# N/A N/A   *Y737S 
                              Mutations in the gyrA, gyrB, parC and parE in the S. epidermidis isolates. *Putatively novel mutations; # isolates resistant to rifampicin only 



























geh, lip, sspA, nuc, 
gelE, EF0818, 
stp,sprE, 









geh,lip,nuc adsA,capC,manA - hlb, cylR2 - -  





sspB, geh, lip, sspA, 
nuc, gelE, EF0818, 
stp,sprE 












sspB, geh, lip, sspA, 
nuc, gelE, EF0818, 
stp, sprE 





C68 atl,ebh,ebp,sdrH,flmH sspB,geh,lip,sspA,nuc capB - hlb - -  
C81 atl, ebh, ebp, icaA, 
icaB, icaC, icaR, sdrG, 











C119 sdrH sspB,geh,sspA,nuc - - hlb  -  









flgA, flgB, flgC, 





























C135 - sspB,geh,lip,sspA,nuc - - hlb - -  















C138 - - - - - - -  
C145 atl,ebh,ebp,icaA,icaB,i
caC,icaR,sdrG,sdrH, 
sspB,geh,lip,sspA,nuc - - hlb - -  
































Table 5 MGEs associated with antibiotic resistance genes in the MRSE strains 
Isolate  Contig  Synteny  Plasmid/chromosomal sequence with closest nucleotide 
homology (accession number) 
C35 237 msr(A):recombinase family protein S. warneri strain WB224 plasmid pWB224_2 (CP053472.1) 
376 Tet(K):TPA S. warneri strain 16A plasmid (CP031268.1) 
C36 33 BlaI:BlaR1:blaZ:::transposase:tyrosine-type recombinase/integrase S. epidermidis strain O47 chromosome (CP040883.1) 
59 RadC::erm(A): ANT(9)-Ia:transposase: tyrosine-type 
recombinase/integrase:tyrosine-type 
recombinase/integrase:RadC::::recombinase 
S. aureus strain BPH2056 genome assembly, chromosome 
(LR027874.1) 
81 IS431mec (IS257)::::mecA:MecR1 S. aureus strain Guangzhou-SAU071 chromosome 
(CP053183.1) 
91 relaxase:MobC:cat(pC233)  S. aureus plasmid pC223 (AY355285.1) 
93 relaxase:::cat(pC221):::relaxase S. aureus strain 08-028 plasmid (CP045437.1) 
C38 42 recombinase:CcrB::::IS1182::MecR1:mecA::::IS6-like 
element(IS257) 
S. aureus strain NZAK3, chromosome (LT009690.1) 
54 erm(C):ErmCL S. aureus strain 18082 chromosome 
C40 31 YycH::::IS6-like element (IS257)::::mecA:MecR1 S. epidermidis strain HD66 chromosome (CP040868.1) 
61 Erm(C):ErmCL:RepL S. aureus strain 18082 chromosome (CP041633.1) 
C81 30 BlaI:BlaR1:blaZ:::transposase:XerC:Tn554-related transposase A S. epidermidis strain O47 chromosome (CP040883.1) 
144 Recombinase/integrase:Tn554:ANT(9)-Ia:erm(A) S. aureus strain SR153 chromosome (CP048643.1) 
148 IS6-like element (IS257)::::mecA:MecR1 S. aureus strain Guangzhou-SAU071 chromosome 
(CP053183.1) 
160 cat(pC221):::::Erm(B) S. pseudintermedius strain AH18 chromosome (CP030374.1) 
C119 12 recombinase:BlaI:BlaR1:blaZ:: type I toxin-antitoxin system S. epidermidis strain SE95 plasmid (CP024439.1) 
204 Erm(C):ErmCL S. aureus strain 18082 chromosome (CP041633.1) 
C133 6 TPA:Tn554::IS1182:blaZ:BlaR1:BlaI S. epidermidis strain NCCP 16828 chromosome 
(CP043847.1) 
C135 70 resolvase:CcrB::::IS1182::MecR1:mecA S. aureus strain ER03750.3 chromosome (CP030557.1) 





175 Fst:::msr(A):Mph(C) S. aureus strain ER02243.3 plasmid (CP030478.1) 
C137 31 IS6:blaZ:BlaR1:BlaI:recombinase S. epidermidis strain SESURV_p1_1200 chromosome 
(CP043796.1) 
C138 4 BlaI:BlaR1:blaZ::TN554:TPA S. epidermidis strain NCCP 16828 chromosome 
(CP043847.1) 
37 dfrG:Insertion element (TPA) S. epidermidis strain NCCP 16828 chromosome 
(CP043847.1) 
C145 30 IS1182::MecR1:mecA S. aureus strain NRS484 chromosome (CP026066.1) 
34 GNAT family N-acetyltransferase:APH(3')-IIIa:Peptide binding 
protein::erm(B)::antitoxin: peptide-binding protein: 
IS1216(IS6)::::recombinase 
E. faecium strain VVEswe-R plasmid (CP041269.2) 
36 Lnu(B):::::ant(6)-Ia:sat1):ISEfm1 E. faecium strain Efm0123 plasmid (KR066794.1) 
54 GNAT family N-acetyltransferase:APH(2'')-Ia S. hominis strain FDAARGOS_661 plasmid (CP054551.1) 
















































































































Figure 1 Genetic environment of resistance genes found in the MRSE strains. The genetic environments of genes were determined using the annotated GenBank files. Isolate 










Figure 2a Whole-genome phylogenetic tree annotated with sequence type (ST) assignment, SCCmec types and antibiotic resistance carriage. Gene names 
above the annotation according to antibiotic class as follows (β-lactams: mecA, blaZ; tetracyclines: tet(K), tet(M); macrolide, lincosamide streptogramin B: 
msr(A),erm(A), erm(B), erm(C), lsa(A), mph(C); aminoglycosides: aac(6')-aph(2''), aadD; efflux pump: norA; trimethoprim: dfrG; chloramphenicol: 
cat(pC221), cat(pC233). The profile was generated using Phandango (https://jameshadfield.github.io/phandango/#/). Heat map at the middle indicates 

























Figure 2b Phylogenetic relationship of S. epidermidis isolates in this study and African S. epidermidis (with their 
countries indicated) obtained from PATRIC. The tree consists of two main clades, A and B, defined by the branches. 
Clade B was further organised into sub-clades B1 and B2, which was further organised into B2a and B2b, and 





Table S1 Genome and assembly characteristics of sequenced MRSE isolates from clinical sources 
Isolate ID Size 
(Mb) 
GC% contigs No. of 
RNAs 
No. of coding 
sequences 
N50 L50 
C35 2.9 31.8 552 15 3185 6031 166 
C36 2.8 32.0 177 75 53309 53309 17 
C38 2.7 32.4 61 82 2657 91621 10 
C40 2.5 31.8 53 63 2487 94191 9 
C68 2.8 31.9 140 65 2834 82977 10 
C81 2.8 31.9 268 68 2959 25474 37 
C119 2.4 32.5 1331 34 3385 3259 146 
C122 2.7 31.7 1267 45 3609 9443 65 
C127 2.8 31.8 255 92 2922 31786 27 
C133 2.4 32.0 22 62 2295 348106 3 
C135 2.8 32.2 678 65 3171 9750 72 
C137 1.9 32.1 141 61 1987 24369 23 
C138 2.9 31.9 541 63 3156 20755 35 
C145 2.6 32.2 103 90 2597 126613 7 
C146 2.3 32.0 25 56 2188 171915 4 
C148 2.5 32.5 117 68 2587 315043 3 
Key: N50 = smallest contig of the size-sorted contigs that make up at least 50% of the respective assembly 












Type of clone  Closet global ancestry 
sequence type (ST) 
Source 
ST54 Similar a ST54  Human, Animal 
ST83 Similar a ST83  Human 
ST210 Similar a ST210 Human 
ST2 Similar a ST2 Human, Environment 
ST59 Similar a ST59 Human, Animal 
ST490 Similar a ST490 Human 
ST640 Similar a ST640 Human 










ST297 (TLC1) Similar  ST297 Human 
ST1727 (NC3) Similar  ST1727 Human 
ST44 (AC1) Single-Locus 
Variant (SLV) b 
ST10, ST752 Animal (Food), 
Human 












ST10, ST744 Animal (Food),  
Human 
ST7473 (NB12) Single-Locus 
Variant (SLV) 
ST10 Animal (Food), 
Human 
ST6646 (CB1) Satellite c  None - 








Table S3 Distribution of intact prophage regions among the MRSE strains 
Sample code Intact 
prophages 
Region  Length (kb) No. CDS GC% Phage Resistance 
genes 





1 34   28.44 PHAGE_Staphy_187 - 





1 34   28.43 PHAGE_Staphy_187 - 





1 34 34053 28.44 PHAGE_Staphy_187 - 
2 41.6 41681 32.7 PHAGE_Staphy_StB20_like - 







3 30.4 30449 28.63 PHAGE_Staphy_187 - 
4 24.3 24394 34.24 PHAGE_Staphy_StB20 - 
5 21.6 21691 33.7 PHAGE_Staphy_StB20 - 
C119 1 1 34.1 34102 36.47 PHAGE_Entero_vB_IME197 - 
C122 1 1 42.7 42796 34.14 PHAGE_Staphy_StB12 - 
C127 -  -  -  -  -  - - 
C133 1 1 50.5 50527 34.29 PHAGE_Staphy_StB12 - 







1 44.8 44882 54.65 PHAGE_Salmon_SEN34 - 
3 17.5 17545 55.52 PHAGE_Klebsi_phiKO2 - 
5 40.9 40943 55.52 PHAGE_Staphy_StB20 - 







1 52.2 52234 29.21 PHAGE_Staphy_187 - 
2 41 41071 32.54 PHAGE_Staphy_StB20_like - 
4 35.6 35674 36.21 PHAGE_Entero_vB_IME197 - 
C146 - - - - - - - 






































CHAPTER 5 – CONCLUSION 
The study investigates the molecular epidemiology and genomic profile of clinical coagulase-
negative staphylococci from KwaZulu-Natal, South Africa.  
5.1 Conclusions 
The following were the main conclusions drawn from the study according to the study 
objectives 
 To ascertain the incidence of CoNS from hospitals in the uMgungudlovu District of the 
KwaZulu-Natal Province from blood cultures routinely processed by the central 
microbiology laboratory using culture and biochemical techniques: 
 The overall incidence rate of CoNS was 68.5% (89/130), distributed across 
various hospital departments including ICU, NICU, paediatric ward, paediatric 
OPD, medical wards, emergency departments and surgical ward. 
 To speciate the CoNS using the automated VITEK 2 system: 
 The distribution of CoNS species determined by VITEK 2 was S, epidermidis 
(19.1%), S. haemolyticus (16.9%), S. hominis ssp hominis (15.7%), S. lentus 
(14.6%), S sciuri (5.6%), S. xylosus (5.6%), S. hominis (4.5%), S. succinus 
(4.5%), S. saprophyticus (.4%), S. gallinarum (2.2%), S. capitis (2.2%), S. 
lugdunensis (2.2%), S. auricularis (1.1%), S. arlettae (.1%), S. warneri (1.1%). 
 To determine the susceptibility profile of CoNS isolates against a CLSI-recommended 
antibiotic panel using the Kirby-Bauer disk-diffusion and MIC methods as appropriate:  
 The isolates displayed high resistance against penicillin (100%), cefoxitin 
(76.4%), azithromycin (74.2%), erythromycin (74.2%) and 




 Isolates exhibited lower levels of resistance to gentamicin (2.2%), amikacin 
(4.5%), linezolid (4.5%), tigecycline (5.6%), nitrofurantoin (5.6%), teicoplanin 
(6.7%), and ceftaroline (10.1%). 
 There was no resistance to vancomycin.  
 Multidrug resistance was observed in 76.4% (68/89) of isolates with MAR 
indices ranging from 0.05 to 0.80. Fifty-one different resistance patterns were 
observed in MDR isolates depicting high resistance of the isolates to commonly 
used antibiotics. 
 To identify and characterize antibiotic-resistance and virulence genes in CoNS, their 
associated MGEs and their genetic support/environment using whole genome 
sequencing and bioinformatics tools: 
 Sixty-three isolates were MRCoNS by PCR detection of the mecA gene. The 
mecA gene was borne on the SCCmec mobile genetic element (MGE). 
 Resistance genes conferring resistance to β-lactams (mecA, blaZ), tetracyclines 
[tet(K),tet(M)], macrolide-lincosamide-streptogramin B antibiotic (MLSB) 
[erm(A), erm(B), erm(C), msr(A), and mph(C)], trimethoprim-sulfamethoxazole 
(dfrG), aminoglycosides [aac(6')-aph(2''), aph(3')-III, aadD], chloramphenicol 
[cat(pC221), cat(pC233)], fosfomycin [fosB], were detected in isolates. There 
was generally agreement between phenotype and genotype. 
 Seven mutations were found in gyrA, 4 mutations in parC, but no mutations 
were detected in gyrB. We further found 2 mutations (S486Y and Y737S) in the 
rpoB gene. 
 Various virulence genes, including those involved in biofilm/adherence 
formation (e.g., the ica operon, atl,and ebh), enzymes (e.g. geh, lip, and sspA) 




 Other MGEs found included insertion sequences (including the virulence-
associated IS256), plasmid replicons (mostly Rep10) and phages (mostly 
PHAGE_Staphy_StB20). Other MGEs such as transposons (Tn554) and IS257 
were frequently found as part of the genetic support environment of resistance 
genes. 
 Mechanisms encoding defense against prophages (RMS) and the MGE ACME, 
were also identified.  
 To determine the clonal relatedness and phylogeny of isolates using whole-genome 
sequencing and bioinformatics tools to compare and contrast study strains with others. 
 Phylogenetic analysis found two major clades, A and B, with clade B further 
divided into sub-clades, and that antibiotic resistance gene distribution did not 
coincide with clades. There were no associations of note between clades and 
hosptital/ward type. 
5.2 Limitations  
 The small numbers of CoNS isolates obtained from specific departments made it 
challenging to deduce statistically significant comparisons across the hospitals' 
departments.  
 Considering the importance of identifying patients at risk of CoNS infection, the 
absence of detailed information such as the period of hospitalisation, previous antibiotic 
treatment, immune status of patients, clinical signs and symptoms and co-morbidities 
made it challenging to assess the true pathogenic potential of isolates recovered, even 





 Future studies should consider large numbers of isolates to explain trends observed 
with greater statistical significance. 
 Future studies should be more patient-focused, with the provision of detailed 
patient-level data to assist in the assessment of other factors that contribute to 
pathogenicity/virulence and also to consider confounding factors.   
 There is a need for surveillance of CoNS as emerging opportunistic pathogens.  
 There should be increased education and awareness creation about antibiotic 
resistance and spread to decrease its occurrence, particularly in the clinical setting. 
5.4 Significance of the research 
Antibiotic resistance is an issue of global concern as the use of antibiotics continues to 
rise both in human and veterinary practice, leading to the development of multidrug-
resistant infections, associated with increased morbidity and mortality. The high level 
of multidrug resistance observed and the rich repertoire of resistance genes, virulence 
genes and MGEs call for greater monitoring and evaluation in the South African health 
sector when dealing with CoNS.   
Investigation into the resistance profile, virulence profile, pathogenicity, persistence, 
defense mechanisms, phylogenetic relationships and evolution provides vital insights 
into the genomic underpinnings of the behaviour of CoNS. The study points to the fact 
that there is a need for improved screening of both patients and healthcare workers, 
considering CoNS are abundant on the skin and mucous membranes. Thus, great 
caution should be exercised during invasive medical procedures as well as those that 




There is scanty information concerning the role of CoNS in hospital-acquired 
infections, particularly relating to molecular epidemiology in Africa, with most studies 
reported from Europe and the USA. Thus, the study sought to describe the molecular 
and genomic epidemiology and mechanisms that make CoNS microorganisms of 
interest, using WGS. The use of WGS in this study provided critical information useful 
for the epidemiology of infection, diagnosis and typing, useful to arrive at important 
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